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About This Guide 
The purpose of this guide is to help funders make smart investments in lowering the human and economic 
burden of substance use disorders (SUDs), which currently affect 1 in 12 adolescents and adults in the United 
States, at a cost of hundreds of billions of dollars annually.1 In the following pages, we provide:
• Key issues and context to inform philanthropic decision-making
• Specific high-impact opportunities for philanthropists to make a difference, including examples of non-profits 
implementing those opportunities and, to the extent possible, estimated costs and impacts 
In addition, we include an appendix that explains how our team developed the guidance that appears in this 
document, along with background on our Center’s overall work. 
This guidance was developed with the generous support of the Mistral Foundation.
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The 2013 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) is used by medical 
professionals across the country to diagnose and describe mental health conditions. The 
DSM-5 defines a substance use disorder as the presence of at least 2 of 11 criteria, 
which are clustered in four groups:
•	Impaired control: (1) taking more or for longer than intended, (2) unsuccessful efforts 
to stop or cut down use, (3) spending a great deal of time obtaining, using, or 
recovering from use, (4) craving for substance.
•	Social impairment: (5) failure to fulfill major obligations due to use, (6) continued 
use despite problems caused or exacerbated by use, (7) important activities given up or 
reduced because of substance use. 
•	Risky use: (8) recurrent use in hazardous situations, (9) continued use despite 
physical or psychological problems that are caused or exacerbated by substance use. 
•	Pharmacologic dependence: (10) tolerance to effects of the substance, (11) withdrawal 
symptoms when not using or using less.* 
The DSM-5 suggests using the number of criteria met as a general measure of severity, 
from mild (2-3 criteria) to moderate (4-5 criteria) and severe (6 or more criteria).
 
*Persons who are prescribed medications such as opioids may exhibit these two criteria,  
 but would not necessarily be considered to have a substance use disorder.
Substance Abuse Disorder i
Substance Abuse Disorder
Definitions of substance use disorder
Clinical definition
Working definition for this report
A substance use disorder, in the simplest terms, is the continued use of drugs or alcohol despite trying to stop 
and/or causing harm to self or others. 
 
Number of criteria met
1 2 3 4 5 6 7 8 9 10 11
        Mild (2-3)   Moderate (4-5)             Severe (6-11)
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Executive Summary
Substance use disorders (SUDs), also known as substance abuse or addiction, affect Americans in all walks of 
life. An estimated 20 million or more adolescents and adults in the United States—1 in 12—have an SUD, defined 
as continued use of drugs or alcohol despite trying to stop and/or causing harm to self or others.2 You probably 
know someone with an SUD, but most people with an SUD don’t talk about it. Stigma and shame keep the 
disorder hidden, undertreated, and misunderstood.
SUD symptoms can show up in hurtful or even illegal behaviors that can appear to be simply a matter of choice, 
and it can be difficult to understand why someone can’t just stop. We know that people with SUDs experience 
changes in their brain that make it harder and harder to stop using, but we still have more to learn about why 
that happens and how to prevent it. What we do know is that bringing evidence-based care to SUD patients gets 
results: more people get better more quickly, and the pain and damage the disorder can cause to patients and 
families are reduced. 
Lifting the burden of SUDs has another benefit: reduced costs. America spends billions of dollars a year on costs 
related to SUDs, more than on smoking and obesity combined.3 Unfortunately, this spending is not always well 
targeted, and the rate of SUDs remains steady—as does the harm they cause to patients, their families, and 
communities. The good news is that the context for discussion and treatment of SUDs is changing, and there  
is a wealth of opportunities for philanthropists to make a difference. 
How to read this guide
In the following pages, we present a portfolio of high-impact opportunities to address the negative impacts of SUDs. 
The opportunities are divided into four high-level strategies, with potential non-profit partners and implementers 
highlighted in each:
• Strategy 1: Save lives and reduce SUD-related illness and homelessness right now. There are tools that 
have been shown again and again to save lives and reduce the harm and immediate risk caused by SUDs, as 
well as save money and open the door to treatment. These include overdose prevention medications, clean 
syringe programs, supportive housing, and legal assistance to help ensure that patients’ basic needs are met, 
even if recovery remains elusive. Many of these approaches offer a double benefit: they are compassionate, 
recognizing that those with the most severe SUDs need help; and they save taxpayers money by reducing use 
of costly emergency services. The evidence shows that these tools work, but they aren’t commonly put into 
practice. Philanthropic support can help change that.
• Strategy 2: Improve access to evidence-based treatment. There are opportunities to help extend available 
treatment options to all SUD patients, including particularly vulnerable groups. For many people, treatment is 
synonymous with Alcoholics Anonymous or similar programs. In reality, 12-step programs and support groups 
like AA are just some of the many tools available to help SUD patients recover. Options with good evidence 
of success include cognitive behavioral therapy, mindfulness training, medication-assisted treatment, and 
more. Improving treatment often means simply expanding the range of options. For many patients, access to a 
broader range of treatment options and more comprehensive care can mean the difference between recovery 
or a continued downward spiral. Philanthropic support can make that access possible.
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• Strategy 3: Improve SUD care by changing systems and policies. Health care reform has made it possible 
for hundreds of thousands of Americans to access better mental health and SUD treatment, but broader access 
requires better implementation. Philanthropists can support organizations working with policymakers and 
administrators to ensure that access to care continues to improve and that the care itself is informed by the  
best available evidence.
• Strategy 4: Fund innovation to improve prevention and treatment. The sector continues to grapple  
with big questions about how to prevent SUDs, how to develop and deliver better care, and how to help  
reduce the stigma that keeps so many SUD patients from accessing the care they need. Philanthropists can 
support research to learn more about these questions and pilot new programs to help people benefit from  
that knowledge.
High-impact opportunities in each category are presented in the following pages and summarized in the table on page 
iv. The format of each opportunity varies slightly, particularly between direct service and research or policy work. In 
policy and research, the impact on the people you hope to help is more removed from the point of funding, and the 
chain of cause and effect can be more difficult to see clearly. But those downsides are, for some funders, balanced 
by the potential to impact large numbers of people in lasting and meaningful ways as a result of a single change—
sometimes with the stroke of a pen. Whether in research, policy, or direct service, the common thread across all of the 
opportunities in this guide is the positive impact they can create.
We present a range of options knowing that not every opportunity will appeal to every funder. We hope the broad scope 
allows funders of all types to find opportunities that fit within their philanthropic strategies. No matter what you support, the 
goal is the same: to reduce suffering and harm from substance use disorders, now and in the future. As always, we hope 
the information and opportunities presented in these pages will help donors move from good intentions to high impact. 
  Lifting the Burden of Addiction: Philanthropic opportunities to address substance use disorders in the United Statesiv
High-Impact Opportunities
STRATEGY 1: Save lives and reduce SUD-related illness and homelessness right now
Impact and Opportunity Targeted Populations Featured Organizations Find Out More
Prevent deaths from heroin 
and painkiller overdose through 
naloxone distribution and training
Heroin and prescription painkiller 
users at risk of fatal overdose
Prevention Point Pittsburgh;  
Harm Reduction Coalition
See page 14
Prevent the spread of HIV and 
Hepatitis C and keep the door 
to recovery open through clean 
syringe programs
People who inject drugs, as well as 
their partners and children at risk 
of blood-borne infections 
Prevention Point Philadelphia See page 16
Combat SUD-related homelessness 
through housing support
SUD patients who are chronically 
homeless 
Pathways to Housing 
(Pennsylvania chapter)
See page 18
Help SUD patients with co-
occurring mental health illnesses 
stay housed & financially stable 
through legal support
SUD patients who have co-
occurring mental health illness 
MFY Legal Services See page 19
STRATEGY 2: Improve access to evidence-based treatment
Impact and Opportunity Targeted Populations Featured Organizations Find Out More
Help pregnant women, mothers, 
and their young children get the 
help they need
Low-income women with SUDs, 
along with their families
Meta House See page 26
Break the cycle of substance use 
and incarceration by connecting 
inmates to the care they need 
Individuals with SUDs within the 
justice system
Healthy and Safe Communities 
Initiative (HSCI) of the ACLU 
See page 28
Improve screening, prevention, 
and early intervention for SUDs
Individuals with risky substance 
use habits or SUDs receiving care 
from a hospital, primary care clinic, 
or other non-specialized setting
Institute for Research, Education, 
and Training (IRETA), National 
Opinion Research Center (NORC)
See page 30
Integrate mental health care, 
including SUD treatment, with 
primary care
Individuals with SUDs who receive 
care from a hospital, primary care 
clinic, or other non-specialized setting
Advanced Integrated Mental 
Health Solutions (AIMS)
See page 32
STRATEGY 3: Improve SUD care by changing systems and policies
Impact and Opportunity Targeted Populations Featured Organizations Find Out More
Close loopholes and extend 
insurance coverage to more 
people by supporting  federal 
policy change 
All Americans with SUDs
The Legal Action Center (LAC), 
Coalition for Whole Health
See page 40
Connect care in the correctional 
system to care in the community 
by supporting local policy change
Individuals with SUDs within the 
justice system
Community Oriented Correctional 
Health Services (COCHS), 
Connections Community Support 
Programs
See page 41
Move towards better care for 
everyone by creating a more 
transparent market
All Americans with SUDs Treatment Research Institute (TRI) See page 42
STRATEGY 4: Fund innovation to improve prevention and treatment
Impact and Opportunity Targeted Populations Featured Organizations Find Out More
New research sites for programs 
that have shown promise in 
particular settings
Young children and adolescents 
within the general population
Good Behavior Game (GBG) and 
the Johns Hopkins Center for 
Prevention and Early Education; 
Promoting School-community-
university Partnerships to Enhance 
Resilience (PROSPER)
See page 45
Target risky drinking in 
adolescents with secondary 
prevention
Adolescents who drink alcohol
University of Minnesota's Center 
for Adolescent Substance Abuse 
Research, NORC at the University 
of Chicago, Community Catalyst
See page 47
Learn from successful behavior 
change efforts in related fields
Adolescents among the general 
population
Partnership for Drug-Free Kids;  
Penn Annenberg School; 
behavioral science researchers  
in schools of public health
See page 48
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I have absolutely no pleasure in the 
stimulants in which I sometimes so madly 
indulge. It has not been in the pursuit 
of pleasure that I have periled life and 
reputation and reason. It has been the 
desperate attempt to escape from torturing 
memories, from a sense of insupportable 
loneliness and a dread of some strange 
impending doom.
– Edgar Allan Poe4
Understanding Substance 
Use Disorders: Key Issues 
and Context for Donors
Section I
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Section 1: Understanding Substance Use Disorders
What is a substance use disorder?
A substance use disorder, in the simplest terms, is the continued use of drugs or alcohol despite trying to stop 
and/or causing harm to self or others. It’s a functional definition: does a person’s use negatively impact their 
happiness, relationships, health, or ability to meet their responsibilities—and do they continue to use anyway?8 
Of course, some substances, such as alcohol and prescription drugs, are legal for adults and not problematic 
in moderation or as prescribed. “Use” crosses into “disorder” when these substances are regularly consumed 
despite harm to the user and others. (For a full clinical definition, see page i.)
For many people, their disorder is a chronic condition, like Type 2 diabetes or asthma.9 Relapse is therefore 
a symptom of the disorder, just like an episode of low blood sugar or an asthma attack. As with other chronic 
conditions, good care management can reduce or eliminate these symptoms. 
What differentiates SUDs from many other disorders is that there is an undeniable behavioral element: someone 
who chooses never to try drugs or alcohol will not develop the disorder. The complicating factor is that most 
people who do choose to use drugs or alcohol also will not develop the disorder. For some fraction of those 
people, however, their use will take them down a slippery slope to physiological and psychological dependence: 
their brains will physically alter to reinforce the cycle of craving and use, and their behavior will follow. While 
there is evidence for a genetic component, there is no foolproof way to predict who might become addicted. Any 
number of biological and environmental factors can interact to make someone more vulnerable to the disorder—
or to protect them despite risky personal choices.10 
Finally, while some in the field include tobacco use as an SUD, we have not included it in this report. We focus on 
substances with mood-altering effects and other negative consequences consistent with the functional definition 
outlined above.
TAKEAWAY: A substance use disorder (sometimes called addiction or substance abuse) is the 
continued use of drugs or alcohol despite trying to stop and/or causing harm to self or others. 
Substance use disorders can include both legal and illegal substances.
IN
TR
O
D
U
C
TI
O
N Key Issues and Concepts
Substance use disorders (SUDs) exact a heavy toll on individuals, their families, and society at large. 
An estimated 20 million adolescents and adults in the United States—approximately 1 in 12—suffer from 
an SUD.6 In health care costs, crime, incarceration, and lost productivity, SUDs cost the U.S. hundreds 
of billions of dollars annually; that’s more than the costs of smoking and obesity combined.7 Although 
SUDs are a significant problem in many countries, this report focuses on the United States.
The following section introduces donors to information and concepts important to understanding 
opportunities to lower the social and economic burden of SUDs, including:
• What is a substance use disorder? 
• What causes them?
• Who has them?
• What kind of harm and negative outcomes do they cause?
• What’s the role of stigma, misinformation, and criminal justice?
• Why is this a particularly opportune time for philanthropic investment?
I don’t take pain 
pills for pain. I 
take them to feel 
normal. I wish I 
could remember 
what it felt like 
NOT to be on pills! 
I need help to 
stop. They used 
to make me feel 
good. Now they 
just keep me 
from being sick. 
I’m scared to tell 
my doc … I just 
feel like nobody 
understands. 
What should 
I do from here? 
Who should I 
talk to?
– Anonymous user5
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What causes SUDS?
The short answer is: we don’t really know. Lots of people regularly consume moderate amounts of alcohol or 
experiment with drugs without developing SUDs. We do know that adolescents are the highest-risk age group 
for development of SUDs. Adolescence is a crucial period for brain development. During this time, major shifts 
in development occur in the prefrontal cortex and limbic regions of the brain. These changes are thought to 
contribute to increased risk-taking and novelty-seeking behaviors, such as engaging in substance use.11 Along 
with these brain developments, social influences such as peer pressure are especially pronounced in the 
adolescent period, further increasing teens’ risk of initiating and continuing substance use.12
When it comes to understanding why certain adolescents or adults develop SUDs while others do not, we 
know much less. Studies of identical twins have shown that genetics plays a role, but environmental factors are 
important as well. For both reasons, having a parent with an SUD increases the likelihood that a child will develop 
the disorder.13-15 A 2008 study of national survey data from over 90,000 adolescents found that the strongest risk 
factors were individual risk factors (favorable attitudes toward illegal activities, low perceived risks of drug use, 
sensation-seeking, rebelliousness, and others) and peer risk factors (friends’ delinquent behavior, friends’ use 
of drugs, peer rewards for risky behavior, and gang involvement).16 Having a mental illness such as depression 
is also a risk factor.17 But risk factors are simply associated with a higher likelihood of developing an SUD. The 
causal link is unclear. 
We also know that once a person develops an SUD, the brain can change in ways that make it even more difficult 
to stop using. Recent research has shown that SUDs alter brain structure, and scientists are continuing to learn 
more about what that means. These changes can be one reason why, for many people, recovery isn’t just a 
simple exercise of willpower.
TAKEAWAY: Adolescents are at particular risk for developing SUDs. Certain risk factors such as mental 
illness, genetic susceptibility, and friends who use can make SUDs more likely. The decision to use or not 
use before a disorder develops may be a personal choice, but once a person has developed a disorder, that 
person’s brain changes. At that point, stopping use often requires more than a simple exercise of willpower.
Eventually, the 
little bags weren’t 
enough to stave 
off the symptoms 
of withdrawal, and 
more and more was 
required just to get 
me to work, just to 
get me to sleep, just 
to get through this 
trauma, just to not 
feel how miserable I 
was … and then that 
little promise you 
made to yourself 
– “never ever a 
needle” – begins to 
get broken down …
Now the game is in 
a different league …
it’s been 17 years this 
year since I injected 
my last hit of heroin 
which most certainly 
would have been in 
my neck, the only 
veins I could use 
at that point in my 
addiction.
– Vanessa, 17 years clean18
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Who are the 1 in 12 Americans suffering from substance use disorder?
Over 20 million adolescents and adults in the United States suffer from an SUD (8.5% of the population over age 12).20 
SUDs affect people from all walks of life and might look different from person to person. Examples might include a recent 
college graduate who gets drunk every night in order to manage anxiety, a successful professional who is binging on 
cocaine every weekend, or a rural teen who starts with painkillers and begins injecting heroin when the pills become 
too expensive. SUDs can be found in all socioeconomic groups, among all races and education levels. More than half 
of adults with an SUD are employed full-time, and adults of all education levels are equally likely to suffer from alcohol 
dependence. About one in five young adults ages 18-20 uses illicit drugs, whether or not they’re in college full-time.21 
Alcohol is by far the most commonly abused substance. Marijuana use is becoming more common, while cocaine 
use has decreased.22 Misuse of prescription medicines has been the fastest growing drug problem; it has been 
described as an epidemic by multiple agencies such as the FDA, DEA, CDC, and ONDCP. It is a particular issue 
“among middle class adults, adolescents, and military members and combat veterans who are at risk because of 
chronic pain.”23 Relatedly, heroin use is rising rapidly as a result of prescription opioid addiction.24 Evidence has 
shown that new heroin users often initially abuse prescription opioids before shifting to less-expensive heroin, and 
the number of heroin users nearly doubled between 2007 and 2013.25, 26 Regardless of the trends in individual 
substances, the overall rate of SUDs has remained steady.
TAKEAWAY: People with SUDs are found in all walks of life, from those working steady jobs, to 
celebrities, to the homeless and unemployed. SUD rates are particularly high among young adults, as 
well as certain populations, such as those in jail. While alcohol-related SUDs are the most common, 
SUDs related to painkillers and heroin have been rising.
When I was using 
heroin, very few 
people were aware 
of it. I was ranked 
in the top 4% of 
my 1,000+ high 
school class and 
a member of the 
varsity basketball 
team; not the most 
likely suspect for 
heroin addiction … 
I can go for months 
without being 
tempted to use, 
but if something 
happens to trigger 
my need, the 
craving comes 
back as fresh as it 
was the very first 
week of sobriety.
– Jack, former heroin user, 
nine months clean19 
SUDs are a broad category and might look different from person to person. 
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For sources see page 64.
REPEATED INCARCERATION 
•  6 in 10 U.S. inmates have a substance use disorder.
•  More than half of substance-involved inmates have  
   had multiple incarcerations.
HOMELESSNESS
The incidence of SUDs among the homeless is 4 to 6 
times greater than that of the population at large.
HEALTH CONDITIONS 
including HIV/AIDS and other 
blood-borne infections 
Injection drug use accounts for 
approximately 8% of new HIV infections. 
MENTAL HEALTH DISORDERS
DEATH
•  From 2000-2013, the rate of deaths from heroin and 
   prescription opioid quadrupled.  
•  In 2013, nearly 25,000 people died of opioid overdose.  
Those with substance use disorders disproportionately suffer from the following:
73% of adolescent inpatient substance 
users had co-occurring depression. 
60% of substance-using adolescents 
suffer from anxiety disorder.
Alcohol-abusing adolescents are 6 to 8 
times more likely to have history of 
physical abuse and 18-21x more likely to 
have history of sexual abuse. 
In 2013, 1.4% of adolescents aged 12 to 17 
had both an SUD and a major depressive 
episode (MDE) in the past year. 
359,000
adolescents
In 2013, 3.2% of all adults aged 18 or 
older had both an SUD and another 
co-occurring mental illness.  
People with SUDs are 2x more likely 
to have a mood or anxiety disorder (and 
vice versa).
7.7 million
2x more
adults 18+ years
1 in 5 returning military veterans show 
signs of PTSD or depression.
½ of those have co-occurring SUD.
6-8x
18-21x
RIP
People with substance use disorders are more likely to experience other illnesses, homelessness, and even death.
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What kind of pain and damage do SUDs cause?
Those with substance use disorders also face other serious problems, at rates higher than those in the general 
population. Those problems include: 
• Death
• Health conditions including liver failure, HIV/AIDS, 
and other blood-borne infections such as Hepatitis C
• Homelessness 
• Poverty
• Family upheaval 
• Repeated incarceration
Moreover, individuals with SUDs are not the only people affected. Friends and family suffer as they grapple 
with their loved one’s disorder and its effect on their lives. Damages also occur at the societal level through the 
spending of public resources, incidence of crime and violence, and the opportunity cost as one-twelfth of the 
population struggles to function at full capacity. Taxpayers—with or without SUDs—bear that burden, as SUDs are 
estimated to cost the U.S. over $400 billion in crime, emergency services, and lost productivity costs each year.27 
TAKEAWAY: People with SUDs suffer in real and acute ways that complicate recovery.  The damage 
and cost of SUDS also extends well beyond individuals with the disorder and includes their families, 
communities, and society at large.
I am now 35 and for as 
long as I can remember 
my father has been 
injecting heroin. I 
wonder when I will get 
the call to identify my 
father’s body … I have 
no words of wisdom 
[to offer], as a 10-year-
old boy or a 35-year-
old man watching 
an addict destroy 
everything he loves for 
30 minutes of nirvana. 
I can only say, that an 
addict is never alone in 
their suffering.
 – Geoffrey, son of 
a heroin addict28
For sources see page 64.
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Stigma and misinformation 
Stigma has a direct role in the damage caused by SUDs. The factors underlying the stigmatization are 
complicated. For one thing, while many with SUDs manage to continue meeting the demands of daily life, the 
most visible symptoms of severe SUDs are, in many cases, behaviors that can hurt loved ones, are socially 
unacceptable, or even illegal: not meeting commitments, neglecting children, risky sexual behavior, and crimes 
like theft and violence. The disorder is tied in many people’s minds with these behaviors. In addition, empathy 
can be limited by the fact that many people have personal experience with drugs or alcohol but never develop a 
disorder. It can be difficult to understand why someone else can’t stop if you can. 
Stigma, lack of information, and stereotypes complicate attempts to make progress. Stigma makes some SUD 
patients and their families feel ashamed and afraid to seek help, and it can keep a doctor from providing the best 
care for fear of offending patients by asking about their substance use. The fact that SUDs are a “taboo” subject 
also means that information that could be helpful flows less freely. Doctors may be unaware of recent research on 
more effective treatments and may not know where to send patients for help.30 What’s more, unscrupulous and 
ineffective SUD “treatment” providers can stay in business because when SUD patients and their families don’t 
even acknowledge being in treatment, there is no word of mouth that might help close down a bad provider. Since 
addiction is a politically unpopular topic, even known life-saving, cost-saving, evidence-based programs are hard to 
get funded. Finally, stereotypes and misinformation reinforce the idea that addiction is simply a moral failing, averting 
questions about the role and quality of care providers. For all of those reasons and more, stigma kills.
TAKEAWAY: Stigma around SUDs is a significant and sometimes deadly barrier to effective treatment 
and recovery.
Criminal justice and barriers to treatment
The fact that many individuals with SUDs are using illegal substances also complicates diagnosis and treatment. 
There are lots of questions that could and should be asked about how the justice system treats users of illegal 
substances. For example, many question the logic or fairness behind the fact that 5 grams of crack cocaine 
(generally used within poor communities) carries the same legal penalty as approximately 90 grams of powdered 
cocaine (generally used by wealthier individuals).31, 32 While a broader discussion of the justice system is beyond 
the scope of this report, what is relevant is this: once an individual with an SUD enters the justice system, there 
are a host of barriers that make it extremely difficult for that person to access effective treatment. And without 
treatment, that person is more likely to end up back in jail at an enormous cost to us all.
TAKEAWAY: The fact that SUDs can be a criminal issue as well as a health issue is a complicating 
factor, and those with SUDS who end up in jail face additional barriers to treatment. SUDs, in turn, 
contribute to recidivism and the high cost of incarceration.
I feel horrible. 
I look horrible. I hate 
myself. I am crying 
writing this because 
I just don’t know 
where to go or what 
to do. Everyone 
thinks I am so strong 
but I am not. I feel 
weak and helpless 
and I feel all alone. 
I have pushed so 
many people away 
and I just don’t know 
how to reach back 
out again.
– Anonymous user29
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Right now: A dynamic landscape creating opportunities for change
The good news is that the context for the discussion, prevention, and treatment of SUDs is changing. In part, 
this change is prompted by recent trends. For example, increases in heroin use across a broader range of 
socioeconomic groups are challenging the stereotypes many people hold about drug users, and several states 
have legalized marijuana, changing the context of a criminal drug offense.33, 34 Relatedly, the high and growing 
cost of prisons when many inmates are non-violent drug offenders has prompted reconsideration of criminal 
justice policies.35 
Health care is also shifting the debate. Recent passage of the federal Affordable Care Act (ACA) and the Mental 
Health Parity and Addiction Equity Act (MHPAEA) has opened access to treatment for SUDs and may create 
market incentives for providers to use more effective treatment methods. Several national non-profits working  
on different aspects of SUD prevention and treatment have also been moving toward closer collaboration. 
Finally, this is an area that in many ways is ripe with low-hanging fruit. While there’s certainly additional need for 
research and innovation, there’s also enormous opportunity in simply connecting SUD patients with what we 
already know works and in adjusting policies to align with the knowledge we already have. Philanthropists can 
make a meaningful difference with the tools and knowledge we have right now.
TAKEAWAY: Shifts in conversations around drug policies, changes in health care, new alignments of 
organizations with experience and capacity in addressing SUDs issues, and the development of new 
and more effective forms of treatment are changing the SUDs landscape. It is a promising and dynamic 
time for funders to get involved.
It is not only your 
body that screams 
for the substance. 
Your brain wants it, 
too. Without heroin, 
emotional pain feels 
unbearable.
– Katie, 17 years clean36
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High-Impact Opportunities: 
How Funders Can Help
Section 2
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This section of the report outlines ways donors can help, with specific examples of programs and organizations 
that have either proven their ability to reduce the human and economic burden of the SUDs or have strong 
potential to do so. We present opportunities within four main strategies:
• Strategy 1: Save lives and reduce SUD-related illness and homelessness—an approach sometimes known as 
“harm reduction” (page 11)
• Strategy 2: Improve access to evidence-based treatment through improved screening and better integration  
of mental health and primary care (page 21)
• Strategy 3: Improve SUD care by changing systems and policies (page 35)
• Strategy 4: Fund innovation to improve prevention and treatment (page 43) 
In considering which opportunities to highlight, we used four primary criteria for selection: strength of evidence, expert 
recommendation and consensus, potential for impact, and whether the opportunity had a clear philanthropic on-ramp for 
funders, particularly one that allows a funder to play a strategic role in breaking a bottleneck or leveraging public funding.
Because evidence and impact look different in research and policy than in direct service, opportunities are 
presented slightly differently in those sections. No matter which section they fall into, the common characteristic 
for each opportunity is the potential for meaningful positive impact.
The importance of prevention: An opportunity for innovation. As with many public health issues, prevention is an appealing 
target for many donors—what better way to reduce suffering and save money than by stopping the disorder before it starts? 
When it comes to SUDs, the same holds true: prevention is an important and high-impact target for funders. What sets SUDs 
apart from something like measles, however, is that we don’t yet have proven tools to prevent the disorder from developing. 
That means that the opportunity for philanthropy to make a difference in prevention is greatest in research and innovation. 
There are some existing programs that have demonstrated promise within specific populations, but more piloting and 
research are needed before we can confidently recommend replicating them in schools and communities across the 
country. Conversely, there are programs that are widely implemented without strong evidence that they work. A better 
understanding of how these programs may or may not impact substance use will allow for more efficient spending of both 
public and private dollars. Finally, there are new tools—things like mobile health, genotyping, or even vaccines—that might 
eventually hold the key to successful prevention efforts. Innovation and information together can move the sector toward 
more effective prevention, and philanthropy can help make that happen. (For more on how, flip to Strategy 4 on page 44.)
To learn more about these criteria, our methodology, and the resources we consulted, please see the Appendix 
on page 56.
TH
E 
G
O
A
L Reduce immediate harm from substance use disorders,  
and reduce the burden of the disorder over the long term.
We define social impact as a meaningful and positive change in the lives of others. Here, the relevant 
social impact sought is a meaningful and positive reduction in the burden of SUDs. This includes 
reducing the damage the disorder causes to people with SUDs and their loved ones, reducing the 
overall incidence of SUDs, and reducing SUD-related costs to society. 
Funders can help move towards this goal in multiple ways, by meeting the immediate needs of people 
with SUDs or by supporting research and policy work to shift the field over the long term. 
Strategies and Opportunities
Save Lives and Reduce 
SUD-related Illness and 
Homelessness Right Now
Strategy 1
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STRATEGY 1 Save lives and reduce SUD-related  illness and homelessness right now
 
In emergency situations, the first priority is to save lives, treat injuries, and meet basic needs (food, water, and 
shelter). Only then can other issues, such as better disaster prevention or long-term recovery, be addressed. 
For people with the most clinically severe SUDs, the same logic applies: many of these individuals are in dire 
circumstances, and measures to protect their lives, alleviate their most immediate physical pain and isolation, and 
stabilize their surroundings often need to be taken before recovery from the disorder can even be contemplated. 
There is a very real opportunity for philanthropy to save lives by supporting programs that prevent overdoses 
and the spread of blood-borne viruses such as HIV and Hepatitis C and to provide a more stable environment 
through housing programs and legal support. These approaches can and often do provide a gateway to 
care and to a more complete recovery. However, sobriety is not a prerequisite for the strategies outlined in 
this section. They are notable for their particularly strong evidence base and for their cost savings, benefitting 
taxpayers by easing the economic burden of America’s substance use epidemic. 
Finally, from our conversations with patients and care providers, another benefit emerged: by meeting SUD patients 
where they are and treating them with dignity regardless of their recovery status, these programs can provide links 
to care and a point of human connection for some of the most vulnerable and isolated people with SUDs. 
Saving lives
While alcohol remains the most commonly abused substance, rates of fatal heroin and prescription opioid 
overdose are increasing at an alarming rate in what the media has dubbed America’s “quiet drug epidemic.”38 
Heroin use is on the rise among young adults aged 18-25 and in rural areas. Evidence indicates that this trend 
is a consequence of prescription pain medication users developing an addiction and shifting to injected heroin 
as a cheaper alternative.39-43 In addition to the risk of fatal overdose, injection-drug users expose themselves 
and others to additional health risks, including infection by viruses such as HIV and Hepatitis C. We highlight two 
opportunities to target fatal overdose and the spread of blood-borne viruses. There is strong evidence for the 
efficacy of these cost-saving strategies. Each of these opportunities offers a setting to engage the hardest-to-
reach populations, keeping the door open for recovery while easing the most immediate risks and suffering:
• High-Impact Opportunity: Prevent deaths from heroin & painkiller overdose 
Naloxone is a proven and effective medication to reverse overdose, either through injection or nasal spray. A 
single kit can cost as little as $12, and an average of 50-100 kits distributed will save a life. However, funding 
gaps and restrictive policies keep naloxone out of the hands of many who would benefit from it. Philanthropy 
can fill a much-needed gap in funding direct service and advocacy for community naloxone distribution 
programs. For more details on overdose prevention programs and on how you can help, see page 14. 
• High-Impact Opportunity: Prevent the transmission of HIV and Hepatitis C and keep the door open  
for recovery 
Re-using needles facilitates the spread of blood-borne viruses such as HIV and Hepatitis C. To reduce needle 
re-use, clean syringe programs collect used syringes and dispense clean ones in a non-judgmental setting, 
often alongside other services such as wound treatment, general health care, or simply the use of the site as 
a mailing address. The provision of these services, based on requests from drug users themselves, ensures 
By treating clients 
with respect and 
dignity, we allow 
them to keep 
coming back 
until they may 
eventually be ready 
for treatment.
– Dr. Brian Work, 
Streetside Health 
Clinic, Prevention 
Point Philadelphia37
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client retention while keeping the door open to a fuller recovery. Many sites also offer case management 
services and referrals to treatment for their clients. Contrary to popular myth, extensive research from the 
Centers for Disease Control, the World Health Organization, and numerous other sources has definitively 
concluded that clean syringe programs do not increase drug use or crime.44-46 In addition, every dollar spent 
on clean syringe programs is estimated to save three dollars in future HIV treatment costs, which are often 
borne by taxpayers.47 Philanthropy can fill the gap in funding for such programs, which, despite their efficacy, 
are currently prohibited from receiving federal funds. For more details on clean syringe programs and how you 
can help, see page 16.  
Providing a stable environment
Substance use disorder and homelessness are deeply intertwined.48 The incidence of SUDs among the homeless 
is four to six times greater than that of the population at large.49 The instability of homeless life makes recovery 
more difficult, and many who seek help face a catch-22, as access to housing programs and other support 
services is often contingent on sobriety. As a result, many remain on the streets, their SUDs largely untreated, 
relying on costly public services like shelters and emergency rooms.50-51 Problems of homelessness and instability 
are particularly difficult for patients with co-occurring mental health illnesses. Legal aid can help these patients 
avoid illegal evictions and catastrophic financial hardships.
• High-Impact Opportunity: Combat SUD-related homelessness   
Supportive housing programs provide housing and case management to chronically homeless individuals, 
many of whom suffer from SUDs and other mental illnesses. A subset of these programs known as “Housing 
First” provides these services permanently whether or not clients are maintaining sobriety.52 These programs 
work to reduce homelessness among people with SUDs. For example, a New York City implementation 
where 90% of participants had an SUD (often with another co-occurring mental health issue) was still able 
to keep over 80% of participants stably housed after two years,53 a clear and meaningful improvement in 
quality of life. In addition, supportive housing is associated with other indicators of reduced SUD severity (see 
clinical definition on page i) such as lower use of detox and emergency medicine services. From a societal 
perspective, the cost of providing permanent housing can be offset by the reduction in use of other public 
services like shelters, emergency rooms, and jails.54 For more information on supportive housing programs and 
how you can help, turn to page 18.
• High-Impact Opportunity: Help SUD patients with co-occurring mental illnesses stay housed and financially 
stable    
Tasks like negotiating with health insurance providers, overturning wrongful denial of public benefits, or 
contesting an unlawful eviction can be daunting for anyone. It’s even more difficult for people with SUDs and 
co-occurring mental health issues, and the consequences of failing to manage those tasks can be severe. 
Unmet need for health care, loss of housing, and financial difficulties can together cause stress and instability 
that exacerbate mental health issues and create barriers to recovery. Collaborative models called “Medical-
Legal Partnerships” use civil legal services to address these and other concerns for patients whose medical 
progress might be undermined by legal circumstances.55-59 Once again, such assistance is compelling given 
the resulting savings from the reduced costs of emergency services.60 For more information on medical-legal 
partnerships and how you can help, turn to page 19.
 
If you would have 
asked me last year 
if I was for a needle 
exchange program, 
I would have said 
you’re nuts … 
I thought, just like 
a lot of people do, 
that it’s enabling 
—that you’re just 
giving needles out 
and assisting them 
in their drug habit. 
But then I did the 
research on it, and 
there’s 28 years of 
research to prove 
that it actually 
works.
– Public health nurse for 
Scott County, Indiana, 
site of a 2015 injection-
related HIV outbreak61
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Prevent deaths from heroin & painkiller overdose
Fatal overdoses from heroin and painkillers are increasing at an alarming pace; in 2013 alone, nearly 25,000 people 
died of an opioid overdose, a 400% increase in fatal overdose rates in just over a decade.65 For $40-$55 per kit 
distributed with appropriate training, naloxone kits reverse overdoses and save lives,66 but barriers to access remain. 
The cost of the medicine itself, along with training costs, can be hard for a small program to afford. In many cities and 
states, drug paraphernalia laws can make naloxone kits illegal, and there are no legal protections for doctors who 
prescribe naloxone or members of the public who administer it. At the time of this writing, there are still 18 states that 
have yet to pass a single key protection for naloxone distribution, and only 11 that have passed all of the protections 
suggested by experts.67 
CORE PRACTICE: Community programs distribute naloxone kits and provide training on how to use them so 
that drug users, their loved ones, and first responders such as police can reverse overdoses and save lives. 
Advocacy and training groups help create a supportive policy environment and provide the information and 
coaching direct service programs need to succeed.
Target Beneficiaries: Heroin and painkiller users at risk of fatal overdose
Impact: For every 50-100 kits distributed, approximately one life will be saved. In 2013 alone, naloxone programs 
distributed naloxone and training to nearly 38,000 participants who went on to reverse over 8,000 overdoses.68 
Put another way, for every five persons trained nationally, approximately one overdose was reversed. Programs 
that distribute directly to drug users can be especially efficient. For example, about half the kits distributed by 
Prevention Point Pittsburgh (see following page) are used to prevent an overdose, a rate twice the national 
average. Experts estimate that nationally, 5-10% of reversed overdoses would have been fatal.69 On the ground, 
communities implementing naloxone distribution programs have seen overdose deaths decrease by up to 70%.70 
Cost-per-impact profile: Based on the cost and impact ranges reported above, a back-of-the-envelope estimate 
indicates that it costs $800 - $5500 to save a life through naloxone distribution programs. That’s a wide range, as 
costs vary due to factors such as the cost of the drug itself, which comes in multiple formulations and is currently 
in the midst of a price increase, and costs of training and related program expenses. The population targeted 
also affects that number. While distributing to parents, police, and other groups is important, programs that 
distribute directly to drug users see more kits used when and where they are needed and therefore lower costs 
per life saved.71
HOW PHILANTHROPY CAN HELP: Philanthropists who want to prevent deaths from overdose can fund 
community naloxone distribution centers directly. At the time of this writing, these programs receive some 
public support, but training and advocacy are rarely covered by public dollars. Philanthropy can support 
training and advocacy to make it easier for all naloxone centers to operate in areas where they are needed.
Overdose work 
is simple and 
concrete. It leads to 
lives saved … you 
give people a tool 
and they use it. 
–Eliza Wheeler,
overdose prevention 
specialist63
A guy on the 
street, a stranger 
 to me, had taken 
some of that 
strong gunpowder… 
and overdosed. 
His friends asked 
me if I had narcan 
and I did, so I 
saved him.
–Anonymous user64
High-impact opportunity 1.1
Street crime is no 
longer the clearest 
barometer of our 
drug problem; 
corpses are.
– Sam Quinones,
researcher & journalist62
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Prevention Point Pittsburgh
Prevention Point Pittsburgh (PP Pittsburgh, unaffiliated with Prevention Point Philadelphia) 
distributes naloxone directly to drug users in the community and trains them to reduce overdose 
risk, recognize overdose signs, and reverse overdoses. These trainings are offered in several 
community settings, including the Allegheny County jail, methadone clinics, and other treatment 
facilities. In addition to serving drug users directly, PP Pittsburgh trains health care providers to 
provide naloxone to their patients as needed. PP Pittsburgh also engages in advocacy work, 
including active involvement in the 2014 passage of Pennsylvania’s naloxone access law.
In just under a decade, PP Pittsburgh dispensed 2,298 kits to 1,175 individuals, leading to 
a reported 1,167 successful overdose reversals; roughly 1 in 15 of those would have been 
fatal.69 A back-of-the-envelope estimate indicates that for every 29 kits distributed by 
Prevention Point Pittsburgh, a life is saved. PP Pittsburgh estimates the cost of training and 
providing naloxone to one individual ranges from $40-55. It therefore costs PP Pittsburgh 
approximately $1,200-$1,600 to save a life.
This estimate suggests that PP Pittsburgh is more cost-effective than the national average. This 
is, in part, because, while they do distribute to family members and others likely to be first on 
the scene of an overdose, their primary target is people who inject drugs. Going straight to the 
users makes it more likely that the kits will be in the right place at the right time, leading to 
more kits used when they are needed and more lives saved.
The Harm Reduction Coalition
The Harm Reduction Coalition (HRC) works in states and at the federal level to advance support 
of overdose prevention and clean syringe access. They also provide capacity-building services 
to state agencies and non-profits seeking to implement programs in their own communities.
For example, HRC began work in Colorado in 2010. Through a combination of assistance to 
care providers and advocacy to the state legislature, HRC enabled the formation of three 
new naloxone distribution sites. The programs are small and still relatively new, but one site 
reports 400 kits distributed and 155 overdose reversals reported since its start in May 2012.
HRC also piloted overdose prevention within the San Francisco County Jail, placing naloxone 
kits in trained inmate’s property for access upon release. By July 2014, almost 200 inmates 
had opted to receive naloxone kits in their property. HRC also collaborated with The 
California Coalition of Women Prisoners to develop overdose prevention materials and 
programming for women in California state prisons. 
TAKE ACTION
To support an existing program like Prevention Point Pittsburgh directly, visit South Boston Hope & Recovery 
Coalition’s national database at www.hopeandrecovery.org to find a naloxone distribution program in your community. 
To help train and support communities looking to expand access to life-saving naloxone kits, visit the Harm 
Reduction Coalition’s website at http://harmreduction.org. Their site also provides fact sheets and materials  
for those interested in advocating for better overdose prevention.  
TIPS
For the greatest bang 
for buck, funders 
should seek out:
• Centers that 
distribute directly 
to drug users as 
well as to family 
members and first 
responders. The 
evidence shows 
that distributing 
to users results in 
more lives saved 
per kit. 
• Advocates with 
strong ties to state-
level decision-
makers. Much of 
the law and policy 
around naloxone 
distribution is 
decided at the state 
level. Groups with 
close connections 
to state-level 
decision-makers 
understand the 
local context and 
can advocate more 
effectively.
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High-impact opportunity 1.2
Prevent the transmission of HIV and Hepatitis C  
and keep the door open for recovery
Lack of access to clean syringes and health care poses a serious health risk to users and to the wider public, 
as reusing needles facilitates the spread of blood-borne viruses such as HIV and Hepatitis C. For less than $1/
syringe, clean syringe programs are a cost-effective way to prevent the spread of HIV. Despite widespread 
misconceptions, researchers from the Centers for Disease Control, the World Health Organization, and other 
research centers have repeatedly found that they don’t increase drug use.74, 75 Clean syringe programs are used 
widely and receive public funding in nearly 80 countries around the world,76 but the politics surrounding these 
programs in the United States are divisive and a ban on federal funding for syringe exchanges remains in place to 
date.77
CORE PRACTICE: In areas with a high number of people who inject drugs, used syringes are collected and 
clean paraphernalia is dispensed. Many clean syringe programs will also offer other services such as wound 
care, contraceptives, or the use of the clinic as a mailing address.
Target Beneficiaries: People who inject drugs, as well as their partners or children at risk of blood-borne infection
Impact: Eight different reports commissioned on behalf of U.S. government agencies and the World Health 
Organization found that clean syringe programs reduced the spread of HIV.78, 79 In the late 1980s, 30-50% of HIV 
infections in the U.S. arose from injection drug use. Today, this is down to approximately 8%, and evidence shows 
that clean syringe programs are at the heart of this trend.80 In Philadelphia, for example, the cumulative average of 
new HIV infections occurring through injection drug use was estimated at 5.4% of all new infections diagnosed for 
2013 (down from an average of over 30% for 1980-2010).81 
Despite common misconceptions, researchers have repeatedly found that these programs do not increase 
drug use or crime and can actually make for cleaner neighborhoods as discarded syringes are returned to 
exchanges.82, 83 In addition, a number of studies have shown a positive correlation between clean syringe 
programs and reduced drug use, greater treatment entry, and improved treatment outcomes.84, 85
Cost-per-impact profile: A panel of experts convened at the International AIDS Conference in Washington, D.C., 
in July 2012 gave a conservative estimate that every dollar spent on clean syringe programs would save three 
dollars in future HIV treatment costs averted.86 
HOW PHILANTHROPY CAN HELP: Because of the federal funding ban, lack of capital is a major problem for 
clean syringe programs. Philanthropists can fund clean syringe programs directly or can support advocacy to 
encourage increased public funding for this cost-effective intervention.
Needle exchange 
offered us a way 
to say that drug 
addicts are people 
and they have an 
illness that merits 
concern and love…
Until we get people 
into treatment, this 
is a way to take 
care of them.
– Father Errol 
Harvey, formerly 
of Manhattan’s St. 
Augustine Church73
It does not result 
in an increase in 
drug abuse, and it 
does decrease the 
incidence of HIV 
… The idea that 
kids are going to 
walk out of school 
and start using 
drugs because 
clean needles 
are available is 
ridiculous.
– Dr. Anthony Fauci, 
National Institutes of 
Health (NIH)72 
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Prevention Point Philadelphia
Prevention Point Philadelphia (PP Philly, unaffiliated with Prevention Point Pittsburgh) began as 
an underground operation by local AIDS activists in 1991. It was officially sanctioned a year later 
when the Board of Health declared a public health emergency in response to the HIV/AIDS 
epidemic sweeping the city.87 In the years since, PP Philly has become part of Philadelphia’s 
broader medical community, with links to teaching hospitals at the University of Pennsylvania, 
Thomas Jefferson University, Temple University, and Drexel University.
With an annual operating budget of under $400,000 for its syringe program, PP Philly serves 
over 4,500 regular clients (many of whom are also exchanging for friends, bringing PP Philly’s 
services to over 40,000 individuals overall) and distributes some 1.5 million syringes each 
year. In addition, PP Philly provides HIV and Hepatitis C testing services, rudimentary health care 
(including a wound clinic requested by their clients), naloxone overdose prevention training, case 
management, and referrals to social services and drug treatment. In-house, PP Philly provides 60 
slots in a suboxone opiate substitution program (known to be an effective treatment for heroin 
and painkiller addiction) and 44 places in HIV Antiretroviral Therapy (ART). 
They also offer auxiliary services. For example, in 2015, the organization partnered with a local 
shelter organization to provide 25 emergency beds for homeless men. Clients can also use PP 
Philly as a mailing address. 
The organization has a team of 15 paid staff and approximately 750 volunteers operating out of 
a fixed site in Philadelphia’s North Kensington neighborhood and from six designated locations 
via its mobile van. 
TIPS
To achieve the highest 
impact, look for 
programs adhering 
to accepted best 
practices, including: 
• No limitations on 
number of syringes a 
user can obtain; 
• No requirements for 
identification or other 
legal documents; 
and 
• Provision of other 
health services 
tailored to the 
needs of the local 
community, such 
as wound care and 
contraception.
TAKE ACTION
Visit Prevention Point Philadelphia’s website at http://harmreduction.org/connect-locally/pennsylvania/prevention-
point-philadelphia, or find similar programs in your area by visiting the mapping tool and database offered by the 
North American Syringe Exchange Network at https://nasen.org/directory/. 
Funders can also support advocacy to increase access to clean syringes, such as the Harm Reduction 
Coalition’s campaign to reverse the ban on federal funding for clean syringe programs. (For more about the 
Harm Reduction Coalition, see page 15.)
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High-impact opportunity 1.3
TIPS
Not all housing 
programs are the same: 
• Housing First 
programs provide 
housing and case 
management, 
whether or not 
residents are 
maintaining sobriety. 
They are most often 
“scattered site,” 
which means that 
clients aren’t all 
housed in a single 
building but rent 
apartments through 
private landlords 
just like any other 
leaseholder.  
• Sober housing 
programs provide 
housing only as a 
reward for sobriety—
and withdraw it as 
a consequence for 
drinking or drug use. 
Both programs can 
be helpful, depending 
on the population 
served. While some 
with SUDs see sobriety 
requirements as a 
barrier to entry, others 
may welcome them as 
a needed incentive.
TAKE ACTION
Several options exist for the kind of supportive housing that keeps SUD sufferers safe, keeps the door open 
for recovery, and saves societal costs. The 100,000 Homes campaign lists programs across the country 
at 100khomes.org. For more information about Pathways to Housing PA and the Housing First model, see 
pathwaystohousingPA.org.
Pathways to Housing PA
Pathways to Housing PA implements the Housing First model, housing clients regardless of their 
substance use. According to a 2011 evaluation, 89% of Pathways to Housing PA participants 
remained stably housed five years after entering the program.103 Clients can access services like 
primary care, SUD treatment, and coaching on daily activities such as shopping for groceries. 
Housing is used as a foundation for stability, rather than an incentive for sobriety. Pathways to 
Housing PA partners with the Philadelphia Department of Behavioral Health on a special effort 
targeting chronically homeless SUD patients. 
Note: Pathways to Housing was originally a national network, but local chapters now operate 
independently. A Pathways chapter in New York was closed following financial and legal 
difficulties, but other implementations remain highly recommended by experts in homelessness, 
including the federal agency tasked with homelessness prevention (United States Interagency 
Council on Homelessness).104
Combat SUD-related homelessness 
The incidence of SUDs among the homeless is four to six times greater than that of the population at large.88, 89  
The instability of homeless life makes recovery more difficult, and many housing programs and other support services 
require sobriety as a condition of participation. As a result, homeless SUD patients who can’t maintain sobriety remain 
on the streets, largely untreated, relying on costly public services like shelters and emergency rooms.90 Stable, 
supportive housing can make an immediate positive impact in quality of life for a person with an SUD, while improving 
access to treatment, decreasing the use of emergency services, and ultimately saving public dollars.91-95
CORE PRACTICE: Provide stable housing with supportive services—including options that don’t require sobriety. 
Target Beneficiaries: People with SUDs who are chronically homeless; these are often individuals with co-
occurring mental health disorders.96
Impact: In New York City, over 80% of participants in supportive housing without sobriety requirements remained 
housed after two years.97 In a similar program in Philadelphia, 90% of clients remained stably housed at the 
two-year mark. In that program, clients with severe alcohol use disorders decreased their nights in jail, hospitals, 
and emergency shelters by over 90%, from an average of 88 to 8 nights per year.98 Sober housing has shown 
increased use of SUD treatment services (often required for residents) and improved housing stability.99
Cost-per-impact profile: In Philadelphia, Pathways to Housing PA (see below) pays about $20 per day to provide permanent 
housing to a chronically homeless person. When administration and supportive services such as primary care and SUD 
treatment are included, the total cost is $77 per day.100 For comparison, short-term emergency housing costs the City of 
Philadelphia $34 per day, a night in prison costs about $90 per day, and SUD treatment or mental health hospitals average 
nearly $600-800 per night.101 A back-of-the-envelope estimate indicates that the above-mentioned drop from 88 to 8 nights 
of public service use helped the city avoid costs of about $30 per client per day, or over $10,000 per client per year.102
HOW PHILANTHROPY CAN HELP: Philanthropists can help combat homelessness among people with SUDs 
by funding supportive housing programs in their community. Public dollars fund some of these programs, but 
services are not available to everyone who needs them. 
High-impact opportunity 1.4
Help SUD patients with co-occurring mental illnesses stay housed and financially 
stable
SUDs and other mental health issues are often co-occurring, and the combination can make it particularly difficult 
for patients to navigate unexpected issues such as a drop in income or an illegal eviction notice. These bumps in 
the road can then spiral into a worsening situation, creating obstacles to stability and recovery.
CORE PRACTICE: In medical-legal partnerships, attorneys train health care providers to recognize when a legal 
issue such as improper denial of treatment is impeding recovery. Attorneys also work directly with mental health 
patients to help resolve issues that patients have difficulty managing on their own. 
Target beneficiaries: SUD patients with co-occurring mental health illness
Impact: Medical-legal partnerships can keep patients in their homes and out of financial crisis. For example, MFY 
Legal Services (highlighted below) served 1,600 clients in 2014, preventing 200 illegal evictions and helping their 
clients access needed public supports for which they are eligible.
Cost-per-impact profile: Medical-legal partnerships save taxpayer dollars. For example, the average cost to 
shelter a homeless family in New York City is over $37,000 per year, while it costs MFY one-tenth that amount 
to prevent that family’s eviction.105 A Virginia study found that every $1 spent on legal aid yielded over $5 in cost 
savings from reduced use of emergency services, increased tax dollars paid to the state, and other benefits; a 
New York evaluation found similar results.106-108
HOW PHILANTHROPY CAN HELP: Donors can fund medical-legal partnerships directly to serve the unmet 
need for such support. They can also work with national groups to support new local partnerships or 
strengthen training and awareness-building within the medical and legal communities.
TAKE ACTION
For more information about MFY and how to support its work, see their website at mfy.org. To identify similar 
medical-legal partnerships in your community, explore the mapping tool provided by the National Center 
for Medical-Legal Partnerships at www.medical-legalpartnership.org. For those interested in supporting the 
development of a new partnership, the National Center also provides toolkits and other guidance.
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TIPS
Some organizations 
may also provide 
legal help outside 
of the medical-legal 
partnership model. For 
instance, MFY runs 
a project targeting 
unscrupulous “three-
quarter house” 
operators, who recruit 
graduates of SUD 
treatment programs 
with promises of 
supportive housing—
but in reality provide 
coerced sham 
treatment as part 
of a Medicaid fraud 
scheme. Patients 
who request different 
treatment are 
summarily (and illegally) 
evicted.
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Services serves the particular needs of mental health patients, including those with co-
occurring substance use disorders (about 40% of their client population). The Mental Health 
Law Project has relationships with all 11 public hospitals in New York City and receives referrals 
from mental health care providers who have identified a legal need affecting a patient’s 
health. The major civil legal needs of this community include preventing unlawful eviction, 
wrongful termination, and improper denial of health care or public benefits.
For approximately $100,000 yearly (including benefits and supervision), an MFY attorney can 
serve about 200 clients. Their legal support reduces the need for costly emergency services 
by preventing approximately 30 illegal evictions and helping clients access $180,000 in public 
assistance for which they are eligible, a return of up to $1.80 on the dollar. 
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Improve Access to 
Evidence-Based Treatment
Strategy 2
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STRATEGY 2 Improve access to  evidence-based treatment
Substance use disorders can look very different from one person to another, and there is no single silver bullet 
treatment that works for everyone. As the science behind treatment continues to improve, however, there are two 
things we can say with certainty. 
First of all, there is a basic need to extend access to evidence-based care. The treatment most substance use 
disorder patients receive today is simply … nothing. Only 1 in 10 SUD patients receives care at a specialized 
treatment facility.110 Most individuals with SUDs are never referred to treatment, and for those 1 in 10 who 
are referred, many find that they are not offered a full range of treatment options. For certain vulnerable or 
institutionalized groups, such as pregnant women and prison inmates, access to treatment of any kind is 
particularly difficult.
Second, the need for an individualized and adaptable approach provides the common thread for interventions 
that effectively treat SUDs. Funders should be wary of any single approach that claims to have cornered the 
market on effective treatment, eschews all other interventions, and places the burden of failure solely on the 
“readiness” (or lack thereof) of a patient. High-quality, evidence-based treatment is not any single therapy, 
but the practice of drawing upon the full spectrum of what we know works. In practice, that means integrating 
clinical expertise, patient values and preferences, and research evidence into the decision-making process for 
patient care.111-112 Evidence-based tools (sometimes called treatment modalities) include different types of talk 
therapy, incentives for reduced use, medications to reduce cravings, versions of 12-step therapy, and many more. 
In addition, many of these can be combined for a more-tailored fit. Case managers, for instance, can help patients 
access and balance the treatments that are right for them. Availability of a particular treatment is often unrelated 
to the strength of evidence for that treatment. For example, while evidence for the effectiveness of medication-
assisted treatment is much stronger than that for the effectiveness of 12-step programs, the latter are much more 
widely available within treatment centers. 
 It’s like getting the 
same antibiotic for 
a [drug]-resistant 
infection— 
eight times.
– SUD patient who 
cycled in and out 
of 12-step-based 
treatment programs 
without being offered 
other treatment 
options109
Clinical expertise
Evidence-based 
treatmentPatient values  
& preferences
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This section outlines four opportunities to change this situation, getting more people access to the treatment they 
need. The first two strategies focus on breaking the cycle of substance use by extending care to populations 
with particularly high barriers to care. The second two strategies work to ensure greater access to specialized 
treatment for the general population.
Breaking the cycle for high-risk groups
Drug and alcohol use during pregnancy can put a woman at risk of potentially fatal complications,113 and can 
increase the risk that a baby is born too soon or with a health complication.114-118 Many women are afraid to seek 
prenatal care or admit their substance use, fearing that they will be judged by care providers, faced with criminal 
charges,119 or even separated from their existing children.120 Once children are born, parental substance use 
increases the risk of child abuse and neglect,121 as well as the risk that the child will go on to develop an SUD.122, 123 
While many would not think of inmates as a vulnerable population, incarceration makes it difficult to access 
treatment—not just within the prison, but in the community after release. This is a population with high need; 
approximately 6 in 10 U.S. inmates have a substance use disorder, exacerbating the challenges they face upon 
release and making recidivism and its accompanying costs to society all the more likely.124 Recently released 
individuals with SUDs are also at elevated risk of fatal overdose, as they may return to substance use without 
realizing that abstaining during incarceration has lowered their tolerance. For those individuals, the dose that 
used to get them high is now deadly.125 
• High-impact opportunity: Help pregnant women, mothers, and their young children get the help they need 
The most effective programs for women are residential, offer gender-specific programming, involve children 
and families, and provide housing and comprehensive support services.126 Such interventions can help women 
recover from their SUDs, gain parenting skills to strengthen their family, and retain/obtain custody of their 
children. They also ensure that newborns get the care they need to minimize harm from substance exposure 
and that young children receive specialized support. However, such intensive programming is expensive to 
provide and, therefore, rarely available to low-income women. To find out more and learn how philanthropy 
can help low-income mothers and families move toward recovery, turn to page 26. 
• High-impact opportunity: Break the cycle of substance use and incarceration by connecting inmates with 
the care they need 
Low-income individuals in many states rely on Medicaid, which in most states is terminated during incarceration 
but can be renewed upon release. However, the difficulty in re-enrolling can present a major barrier to care. 
Connecting pre-trial detainees, current inmates, and formerly incarcerated individuals with Medicaid allows 
them to access mental health care, including SUD treatment, seamlessly upon re-entry into the community. 
This care can keep them alive and on track to recovery and a fresh start. Moreover, the concurrent reduced 
recidivism and lower health care costs can result in cost-savings to taxpayers. To find out more and learn how 
philanthropy can support increased treatment enrollment and reduced recidivism, turn to page 28.  
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Improve screening, early intervention, and access to mental health care for the general 
population
Primary care and the emergency department are the most common points of care for most Americans, but 
physicians are often underequipped to identify, treat, or manage substance use disorders.127 There are two 
simple strategies that can help. Health care providers can check early-onset SUDs before a full-blown condition 
develops through effective Screening and Brief Intervention and can deliver specialized evidence-based 
treatment through Collaborative Care models. 
• High-impact opportunity: Improve screening and early intervention for SUDs 
There is a simple protocol that allows health care providers to quickly identify risky or problematic substance 
use, intervene briefly if appropriate, and refer patients to more intensive treatments when warranted. Patients 
answer a few screening questions about use. For those who report risky use, the care provider follows up with 
a brief discussion about the risks of use and the options for cutting back. Finally, the provider gives a referral 
to treatment for those whose use is severe enough to warrant treatment. This is known as SBIRT (Screening, 
Brief Intervention, and Referral to Treatment), and it has shown promise in reducing alcohol use and related 
negative outcomes such as drunk driving and sexually transmitted infections. Moreover, studies have shown 
that every dollar spent on SBIRT can generate cost savings in health care of between $3.80 and $5.60. 
Excitingly, it’s also a promising avenue for research into SUD prevention among adolescents, a particularly 
high-risk group for new SUDs.128 To find out more about how philanthropy can improve screening and early 
intervention through SBIRT, turn to page 30.
• High-impact opportunity: Integrate mental health care, including SUD treatment, with primary care 
Originally developed for treating depression and mental health conditions, the Collaborative Care model 
is characterized by the following: care teams deliver evidence-based, patient-centered care; health care 
providers track outcomes for their entire patient population; and care providers are reimbursed for patient 
outcomes rather than volume of services provided.129, 130 Collaborative Care can improve mental health and 
other risk factors for SUDS and, in some implementations, can directly improve access to quality SUD care. 
There is also a high potential for cost savings. In one study, every $1 spent on this strategy generated $6.44 
in health care savings.131-133 To find out more and learn how philanthropy can help capacity-building efforts in 
Collaborative Care, turn to page 32.
All of the opportunities in this section offer innovative approaches to improve access to effective SUD treatment. 
They extend much-needed care to population groups often unable to access quality care or improve the 
screening and treatment processes currently offered by mainstream health care providers. These strategies 
benefit individuals in need of better treatment and also provide savings to taxpayers by reducing associated 
health care costs. 
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High-impact opportunity 2.1
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Help pregnant women, mothers, and their young children get the help they need
Among pregnant women aged 15 to 44 in the U.S., 1 in 20 are current illicit drug users136 and 1 in 13 report using 
alcohol.137 Children of mothers who abuse drugs and alcohol are at increased risk for a variety of problems, and 
the mothers themselves have a higher likelihood of experiencing trauma or abuse.138 Drug and alcohol use during 
pregnancy can lead to negative effects on the baby, including congenital anomalies and an increased risk of 
developing an SUD in the future.139, 140
CORE PRACTICE: Residential programs specifically designed for pregnant women and their children offer 
gender-specific and trauma-informed treatments, providing comprehensive support services for the entire 
family.
Target Beneficiaries: Low-income pregnant women and mothers with SUDs, along with their young children
Impact: Participants in these comprehensive, tailored programs showed reductions in substance use and 
improved birth outcomes, with increases of 20-30 percentage points in the rate of babies born full term or at 
healthy weights.141 There can also be impacts on important related factors, such as parenting skills and whether or 
not a child is placed in state custody. Compared with mothers in regular treatment programs, mothers treated in 
these tailored, family-based programs are twice as likely to be reunited with their child.142 While the available data 
are not sufficient to yield a confident prediction about second-generation prevention, these improvements have 
the potential to reduce the biological and environmental factors that increase a child’s risk of developing a future 
substance use disorder.
Cost-per-impact profile: Costs vary by location, but implementer Meta House (see following page) requires 
$6,750 in philanthropic funding (leveraging additional public funding) to provide a pregnant mother, newborn, and 
additional young child with three months of specialized treatment. Potential impacts include a threefold increase  
in the mother’s likelihood of remaining abstinent from drugs and alcohol for at least six months after her child’s  
birth (from around 25% to around 80%); a reduced risk of low birth weight and prematurity for babies born to 
mothers in treatment; and increased likelihood that mothers with children in foster care can be reunited with  
their children.143
HOW PHILANTHROPY CAN HELP: Organizations like Meta House rely on philanthropy to fill gaps in public 
funding, enabling women to access the treatment they need for as long as they need it. For example, 
Milwaukee County currently covers 75 days of a woman’s treatment at Meta House; other sources of funding 
are often needed to extend treatment until a woman has successfully transitioned out of the program.
I’ve learned about 
how using drugs 
covered up the hurt I 
was feeling … 
I feel so much more 
[now], and it’s painful 
but a blessing and a 
joy. I’ll never forget 
when the baby first 
kicked. I’m already 
getting to know her 
–I know when she’s
hungry or wants to
sleep.
– Arielle, former cocaine
user, mother of 2, 
graduate of Meta House134
I needed time. 
I didn’t know how 
long it was going 
to take. I knew I 
needed TLC for a 
longer period than 
I would get at a 
traditional rehab. 
I was sick, I was 
really, really sick.
– Katie, former cocaine
and heroin user, 
mother of 1, graduate 
of Meta House135
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TIPS
Best practices for 
comprehensive mother 
and family care include:
• Case management
• Individual, family, and
group therapy
• Safe housing for
women and children
in their care
• Services for children
(e.g., play therapy,
academic assistance)
• Medical, mental
health, and prenatal
care
• Parenting education
and coaching,
including individual
instruction about
infant care
• Education & support
for additional family
members
TAKE ACTION
To support Meta House, visit their website at www.metahouse.org. To find similar programs in your 
community, see our website for recent grantees from SAMHSA’s Services Grant Program for Treatment for 
Pregnant and Postpartum Women (www.samhsa.gov/grants/gpra-measurement-tools/csat-gpra/csat-gpra-
ppw), which have been recognized as high-quality programs. Or, use the program criteria listed in our tips (at 
right) to identify a similar program in your community. 
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Meta House has been treating women with SUDs in Milwaukee, WI, since 1963. Women and 
children at Meta House are a high-risk, high-need population, with disproportionately low 
education, high unemployment, and frequent homelessness. Over 90% of women at Meta 
House have suffered trauma or abuse. To serve this population, Meta House’s residential 
program provides a wide range of comprehensive services for up to 35 women and 20 
children at a time, including gender-specific and trauma-informed care. For example, while 
many treatment models emphasize a patient’s powerlessness over drugs or alcohol, Meta 
House women—having experienced powerlessness throughout their lives—often need a 
sense of empowerment to change their behavior. 
Another key component of Meta House’s model is the space for children. It was one of 
the first treatment centers in the country to allow children to stay in treatment with their 
mothers. They offer child-specific services, such as filial play therapy, in which therapists 
coach mothers and help support healthy child development through playtime. They also offer 
parenting education and ways to engage fathers and father figures, such as through a Father 
Engagement Specialist or Family Nights. 
Impacts for mothers at Meta House include increased abstinence from alcohol and illicit 
drugs and healthier birth outcomes for babies. Women who participated in treatment also 
reported 33% fewer days of experiencing mental illness symptoms. At intake, approximately 
15% of Meta House women with minor children were living with those children. Six months 
after treatment, however, almost half (48%) of the children of Meta House women had either 
remained in their mother’s care, been reunified with their mothers, or had increased visitation. 
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Break the cycle of substance use and incarceration  
by connecting inmates to the care they need
Approximately 6 in 10 U.S. inmates have a substance use disorder, and those with an SUD are less likely to stay 
out of prison once their term is over.145 Access to treatment for this group is important to keep them out of jail, 
but administrative hurdles can be significant. Low-income individuals in many states rely on Medicaid, which in 
most states is terminated during incarceration but can be renewed upon release. When individuals lose their 
Medicaid coverage during incarceration, re-enrolling can be a slow and arduous process, delaying or blocking 
access to the treatment they need to help them stay sober. The result: high rates of relapse, fatal overdoses, 
and parole violations leading to repeated incarcerations, with a hefty price tag for individuals and taxpayers. 
Simplifying the process of Medicaid enrollment can get more care more quickly to this high-need population, 
saving lives along with taxpayer dollars.
CORE PRACTICE: Helping detainees and people on criminal justice supervision enroll or re-enroll in 
Medicaid allows them to access mental health treatment (including SUD care) immediately upon release, 
reducing the risk of fatal overdose and facilitating successful re-entry into the community.
Target Beneficiaries: Individuals who are involved in the criminal justice system, either as detainees (pre-trial) or 
inmates. Approximately 60% of this population has a SUD.146 
Impact: Improved access to evidence-based treatment for detainees and inmates, which likely leads to 
reductions in fatal overdose, recidivism, and their associated costs. Research from the state of Washington 
found that improving treatment access for justice-involved individuals with a history of substance use disorder 
can slow health care spending for that population, resulting in overall health care cost savings of $1,944 per 
member per year.147
Cost-per-impact profile: The Healthy & Safe Communities Initiative of the ACLU of San Diego and Imperial 
Counties (see next page), a leading implementer, operates on a budget of approximately $120,000 per 
year. In their first year of operation, they have facilitated Medicaid enrollment for over 2,100 individuals, with 
approximately 200 more awaiting enrollment decisions. This translates to a philanthropic cost of $50-$60 
per enrolled individual. That cost per enrollee will continue to decrease with time, as the greatest investment 
of time and money is in the up-front costs to develop and pilot the enrollment strategy. In addition, as noted 
above, similar efforts in Washington state returned nearly $2,000 in health care cost savings per individual.
HOW PHILANTHROPY CAN HELP: Funders who want to increase access to care and reduce recidivism can 
fund capacity-building to help organizations like the ACLU of San Diego and Imperial Counties extend their 
services and share what they’ve learned about what works.
Since 1970, the 
United States 
prison population 
has risen 700%. 
Now, with 5% of the 
world’s population, 
the U.S. has 25% of 
the world’s prison 
population. One in 
99 adults is living 
behind bars in the 
U.S., marking the 
highest rate of 
imprisonment in 
American history—
and 60% of those 
inmates have a 
substance use 
disorder.144
 
– National Center 
on Addiction and 
Substance Abuse, 
Columbia University
High-impact opportunity 2.2
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TIPS
Funders looking to 
support changes 
to criminal justice 
systems can look for 
advocates with strong 
connections to state 
and local decision-
makers. As the HSCI 
example illustrates, 
sometimes small, 
technical changes can 
be powerful solutions,  
but it’s difficult 
to identify those 
opportunities without 
an inside perspective 
on the way systems 
and administrative 
barriers work. 
TAKE ACTION
To support the Healthy & Safe Communities Initiative, visit their website at www.aclusandiego.org. Other 
organizations whose work includes SUD treatment access for prison populations are the Legal Action Center 
and COCHS, profiled on pages 40-41 of this guide.
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Imperial Counties
The Healthy and Safe Communities Initiative (HSCI), facilitated by the ACLU of San Diego and 
Imperial Counties,  works to increase Medicaid enrollment among individuals who are incarcerated, 
formerly incarcerated, or under criminal justice supervision. The HSCI is comprised of local community 
clinics, reentry service providers, and advocacy organizations. The HSCI collaborates with the local 
Sheriff’s, Probation, and Health and Human Services Departments to identify mechanisms to make 
Medicaid enrollment smoother for re-entry or release, minimizing dangerous interruptions of care.
 
From July 2014 to April 2015, the program connected over 2,100 re-entering individuals 
(approximately 65% of whom have an SUD) with health care coverage through Medicaid. Over 
230 additional individuals are currently in the process of enrollment (as of April 2015).148
The HSCI operates on a budget of approximately $120,000 per year, which includes funding 
for a full-time staff attorney to lead the project and the part-time costs of supporting staff. 
The project is entirely philanthropically funded; funders have included the Open Society 
Foundations, the California Endowment, and the Parker Foundation.
In addition to providing technical assistance to the Medicaid enrollment project, HSCI works 
to reform the systems that influence care within and outside of the correctional system.149 For 
example, recent projects include: 
• Developing toolkits for working with law enforcement on Medicaid enrollment programs
• Coaching to other initiatives engaged in similar efforts 
• Working with advocates across the country to support policies that increase access to care, 
such as allowing inmates to make an appointment with a community care provider before release 
Future work will include impact evaluation to help understand exactly how Medicaid coverage 
affects the way these populations access care, as well as continued capacity-building efforts 
around the country. The Initiative plans to work towards systemic change to increase access to 
care, including advocating for Medicaid-funded supportive housing and specialized Medicaid 
programs for individuals with SUDs.
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High-impact opportunity 2.3
Improve screening, prevention, and early intervention for SUDs
Primary care and the emergency department are the most common points of care for most Americans, but health 
care providers in both settings are underequipped to identify, treat, or manage substance use disorders.151 Less 
than 20% of primary care providers (PCPs) feel “very prepared” to identify the condition, and most patients with 
SUDs say their PCP did nothing to address their substance abuse.152 The result? Risky alcohol and drug use goes 
undiagnosed and unchecked, opening the door to a full-blown disorder and all of the negative impacts that follow. 
CORE PRACTICE: All patients in hospital emergency departments, primary health clinics, or other health 
care settings automatically undergo a quick screening to assess their alcohol and drug use. If their use puts 
them at risk of developing a serious problem, they receive a brief intervention that focuses on raising their 
awareness of their substance use-related risks and motivating them to change their behavior. Patients who 
need more extensive treatment receive referrals to specialty care. The entire process is known as SBIRT 
(screening, brief intervention, and referral to treatment).
Target Beneficiaries: Individuals with risky substance use behaviors or SUDs receiving care from a hospital, 
primary care clinic, or other non-specialized setting
Impact: SBIRT can reduce drinking and the risky behaviors that often come along with it. Patients receiving 
SBIRT have reduced drinking by 13-34% compared with controls.153 As drinking drops, so do consequences 
associated with risky drinking. Patients who received SBIRT have shown significant reductions in hospital days 
and emergency department visits over the four years following the intervention.154 Of 100 emergency-department 
patients who screen positive for risky alcohol use, on average 28 will require another emergency-department 
visit in the following year. But if they receive SBIRT, the likelihood decreases by 38% to about 17.155 A recent 
implementation in New York City found that risky drinkers who received SBIRT were 23% less likely to acquire 
new sexually transmitted infections.156 There is also some evidence that SBIRT could decrease marijuana use.157 
Finally, proponents of SBIRT point out that simply identifying the disorder is valuable for the provider seeking to 
manage a patient’s overall care.158
Cost-per-impact profile: A cost-benefit analysis of a hospital-based program found that each dollar spent on 
SBIRT would generate $3.81 in savings from consequent reductions in both emergency department visits and 
hospital admissions, while other reviews have found savings as high as $5.60 per dollar spent.159, 160 
HOW PHILANTHROPY CAN HELP: Primary care clinics and hospitals may be willing to implement SBIRT, but 
making the change isn’t easy. Things like billing systems and patient intake need to be adjusted, and these 
changes need to occur without disrupting current patient care. Philanthropists can fund the training, technical 
assistance, and organizational development support needed for an implementation to be successful. They 
can also fund pilots and new research into SBIRT in non-medical settings such as schools, for high-priority 
populations such as adolescents, and on less-studied substances such as marijuana. 
The idea … 
is deceptively 
simple: What if you 
could stop drinking 
and substance 
abuse problems 
before they 
became serious 
enough to destroy 
people’s lives?
– SAMHSA (Substance 
Abuse & Mental 
Health Services 
Administration)150
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TIPS
Because capacity-
building efforts 
will be specific to 
the implementing 
organization, there 
is no one-size-fits-all 
approach. According 
to IRETA, successful 
implementations 
often have an 
internal “champion,” 
someone who sees 
the benefit of SBIRT 
and is willing to put 
in the effort required 
to incorporate it into 
patient care. Without 
that internal motivator, 
the implementation 
may stall once external 
funding runs out. 
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TAKE ACTION
Donors interested in supporting SBIRT capacity in their communities can work directly with local care p viders or  
can contact IRETA or the NORC via their websites at www.ireta.org and www.norc.org. IRETA is also a great resource 
for donors interested in supporting research into new applications of SBIRT, for example, among adolescents.
The Institute for Research, Education, and Training in Addictions (IRETA) 
and NORC at the University of Chicago
The Institute for Research, Education, and Training in Addictions (IRETA) and NORC at the 
University of Chicago specialize in delivering these capacity-building services, enabling more 
care providers to offer SBIRT—and allowing more patients to reap the benefits. They provide 
up-front capacity-building, such as training for health care providers, as well as ongoing 
support and coaching to ensure that SBIRT is implemented effectively. To successfully 
implement SBIRT in a hospital or clinic, staff need to be trained and the accompanying 
systems—e.g., patient intake protocols and medical billing codes—need to be adjusted as 
well.161, 162  
For more on SBIRT to prevent SUDs in adolescents, see page 47.
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Sources: Top graphic: Gentilello, L. M., Ebel, B. E., Wickizer, T. M., Salkever, D. S., & Rivara, F. P. (2005). Alcohol interventions for trauma 
patients treated in emergency departments and hospitals: a cost-benefit analysis. Annals of Surgery. http://www.ncbi.nlm.nih.gov/pmc/articles/
PMC1357055/; Bottom graphic: Fleming, M. F et al (2002). Brief physician advice for problem drinkers: long-term efficacy and benefit-cost 
analysis. Alcoholism, Clinical and Experimental Research. http://www.ncbi.nlm.nih.gov/pubmed/11821652
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High-impact opportunity 2.4
Integrate mental health care, including SUD treatment, with primary care
While it is not always clear which illness causes the other, substance users often experience symptoms of another 
mental illness, and mental illness can increase vulnerability to drug abuse. In 2013, 7.7 million adults—nearly 
40% of all SUD sufferers—also had another co-occurring mental disorder.164 Treatment for mental health 
issues, including substance use disorders, has historically been separated from other kinds of medical care. That 
separation creates barriers for patients and reduces the quality of care, often while increasing health care costs. 
Health care reform efforts will encourage care providers to integrate SUD treatment and other mental health 
services into their practice,165 but many physicians need assistance to effectively implement a more integrated 
care model.166
CORE PRACTICE: Mental health and SUD treatment are provided seamlessly alongside primary care  
and managed by trained care teams, which include primary care providers and behavioral health specialists. 
This allows a medical practice to reach more patients with the full spectrum of needed care, improving 
outcomes and reducing medical expenses.
Target Beneficiaries: Individuals with mental health issues, including SUDs, who receive care from a hospital, 
primary care clinic, or other non-specialized setting
Impact: Evidence shows that integrated care improves outcomes for mental health disorders such as depression 
and anxiety, known to be risk factors and common co-diagnoses for SUDs. For example, Collaborative Care 
is a particular model of integrated care in which care teams deliver evidence-based, patient-centered care; 
track health outcomes for their entire population; and are reimbursed for patient outcomes rather than volume 
of services provided.167 In a randomized controlled trial of 1,801 patients with depression, Collaborative Care 
patients were three times more likely to have complete remission of their symptoms (25% vs. 8% of control 
group) and over twice as likely to have their symptoms reduced by 50% or more.168-171 Collaborative Care’s 
impact on SUDs is less well-studied, but early evidence is promising. For example, one randomized study of 
traumatic injury survivors admitted to a hospital found that Collaborative Care was associated with decreases in 
alcohol consumption.172 Given that patients with anxiety or depression have double the likelihood of an SUD,173 
Collaborative Care can, at minimum, improve mental health among patients with both conditions and will ideally 
strengthen mental health care overall and help SUD patients achieve recovery more often and more quickly.174, 175
Cost-per-impact profile: In the initial trial, researchers found cost-savings of $3,363 per Collaborative Care 
patient per four years, compared with treatment as usual. Savings came from reduced expenses on outpatient 
mental health, pharmaceuticals, other outpatient care, and hospital-based care, generating up to $6.44 in related 
health care savings per dollar invested.176-178
HOW PHILANTHROPY CAN HELP: As with SBIRT (p. 30), health care providers may be willing to make the 
change to integrated care, but logistics and administrative barriers can be daunting. Philanthropists can fund 
the training, coaching, and organizational development support needed for a medical practice to successfully 
implement integrated care. These implementations can also be great research opportunities, improving the 
field’s understanding of what works in integrated care and what impact it can have on SUDs specifically. 
Collaborative 
Care has now 
been convincingly 
shown to meet 
the “triple aim” 
of health reform, 
including improving 
quality of care, 
patient satisfaction, 
patient symptoms 
and functional 
outcomes with 
either no increase 
in costs or reduced 
costs.
– Wayne Katon, 
M.D., University of 
Washington School of 
Medicine163
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TIPS
Because clinics’ needs 
vary so widely, there 
is no “typical” case. 
However, existing 
projects can provide 
useful examples of 
Collaborative Care 
implementation. 
For example, an 
implementation of 
Collaborative Care 
in eight rural primary 
care clinics is expected 
to provide better 
mental health care for 
approximately 8,000 
adults at a cost of 
$750 per patient. The 
project is funded by a 
$2M Social Innovation 
Fund grant, which was 
matched by the John 
A. Hartford Foundation. 
Each clinic was then 
required to match its 
award. 
TAKE ACTION
Funders interested in improving integrated care capacity can work directly with local care providers or can 
contact AIMS via their website at www.aims.uw.edu for more information. 
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The AIMS (Advancing Integrated Mental Health Solutions) Center is a research center at the 
University of Washington dedicated to helping organizations put the Collaborative Care model 
into practice. To this end, AIMS engages in three kinds of activity: coaching and support to 
health care organizations seeking to implement Collaborative Care, workforce training in 
integrated care, and research on new populations and settings. 
An engagement between AIMS and an organization implementing Collaborative Care— 
a network of health clinics, for example—proceeds as follows:
• Lay the groundwork: Help the clinic develop a clear vision and plan for its implementation 
of Collaborative Care, including hiring plans and necessary changes to relevant protocols.
• Develop patient-tracking approach: Population-based care—Collaborative Care team 
tracks outcomes over the full patient population—is a core principle of Collaborative Care. 
To do this, providers need a registry that continuously tracks all patients’ progress toward 
clinical outcome goals. 
• Train the workforce: Effective Collaborative Care creates a team in which all of the 
providers work together on a single treatment plan for each patient. For example, if a new 
mother meeting with her primary care provider exhibits signs of post-partum depression, 
the primary care physician can connect her to a therapist who is part of the care team. 
The physician and therapist then work together to come up with a plan that addresses the 
patient’s medical needs along with her mental health needs. AIMS provides training for 
each role and helps the implementer fit these roles into the broader organization.
• Launch and sustainability: AIMS provides tailored coaching and support to clinics and 
organizations post-launch to help them achieve long-term sustainability in terms of team 
functionality, quality improvement, and finances. A critical component is teaching clinics 
how to use outcome measures to determine if stated goals are being met and, if not, how 
to make adjustments. 
The full process typically takes 12-36 months.
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Strategy 3
Improve SUD Care 
by Changing Systems 
and Policies
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STRATEGY 3 Improve SUD care by  changing systems and policies
In the previous section, we presented selected opportunities to improve access to evidence-based treatment 
within the parameters of current laws and regulations. But access for all who need care will remain elusive until 
those rules and regulations reflect the best available evidence. Philanthropy can help make that happen. 
Right now: Complicated regulations, opaque markets, reduced access to care
Currently, a complicated network of rules and regulations determines who gets care and what kind of care they 
receive. Many policies make good sense in isolation and are enacted with the best of intentions. But policy 
change is a slow and complicated process, and it’s not uncommon for policies to remain in place long after the 
evidence indicates a different approach. (The federal funding ban on needle exchanges is one example.) Other 
examples of restrictive policies that don’t align with the evidence include:
• Residential treatment centers with more than 16 beds can’t bill Medicaid for services provided to low-
income adults. The original purpose of the law was to reduce institutionalization of mental health patients, 
but the current impact is a shortage of care for those who would benefit from residential treatment. Treatment 
centers across the nation are unable to expand to meet demand without cutting off access to Medicaid funds 
and putting their business model at risk.179
• The medication buprenorphine is recommended by physicians as the first-line therapy for opioid use 
disorder,180 but federal regulations make it difficult for this medication to be provided within treatment 
centers, requiring doctors to obtain a special certification and prohibiting them from prescribing to more 
than 100 patients at a time.181 While safer prescribing of all opioids is a worthy goal, buprenorphine is currently 
the only one subject to this level of regulation. It is regulated more than opioid painkillers themselves. As a 
result, for many people, it is easier to get the drug that caused their problem than it is to get a similar drug that 
might help solve it.
• Common “Fail First” insurance policies mandate that patients be given lower-cost treatments first, regardless 
of what kind of treatment their doctor recommends.182 These policies were originally designed as cost-cutting 
measures and have been put into place with other medical issues, often with some success. But for SUDs, 
“failing” comes in the form of relapse, which can be deadly.183 The result is that these policies increase the risk 
of death for SUD patients—even as they try to get the help they need.
• Many SUD treatment programs don’t track patient outcomes, and regulations for SUD treatment 
professionals are inconsistent and often lax. For example, a recent review found that only 29 states require 
treatment facilities to provide clinical supervision by fully credentialed counselors, and only 8 states require 
a minimum percentage of clinical staff to be licensed or certified. Only 11 states require residential programs 
to have a physician on staff, only 10 states require any kind of follow-up care, and only 21 states require that 
patient outcomes be tracked.184
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Some of these barriers affect broad groups of SUD patients. For example, the limitations on buprenorphine 
prescriptions are in effect no matter where you live, and federal health care reform affects all insurance plans, 
making those laws important factors in access to care for anyone not able to pay full costs out of pocket. (For 
more detail on how these laws affect health care reform, see sidebar on page 40.)
Some specific populations are especially vulnerable, however. Institutionalized groups, primarily prisoners, 
face additional policy barriers when attempting to access care within the system or after re-entry into their 
communities. Low-income individuals, such as those covered by Medicaid, are less able to pay out of pocket for 
better options if their insurance doesn’t cover the treatment they need.
Changing these policies is a high-impact opportunity for philanthropists. In the following pages, we present 
examples of non-profits with the demonstrated ability to make that change happen, with examples such as:
• Closing loopholes and extending insurance coverage to more people through federal policy change (Legal 
Action Center, p. 40); 
• Connecting care in the correctional system to care in the community through local policy change (COCHS, p. 41);
• Moving toward better care for everyone by using research to enable a more transparent market for treatment. 
(Treatment Research Institute, p. 42). 
Funding organizations that work to change these policies is quite different from funding a direct-service 
organization. The impact on the people you hope to help is more removed from the point of funding, and the 
chain of cause and effect can be more difficult to see clearly.  But those downsides are, for some funders, 
balanced by the potential to impact large numbers of people in lasting and meaningful ways as a result of a 
single change—sometimes with the stroke of a pen. This is not a section full of sure bets, but donors who seek 
game-changing tools for coping with the burden of SUDs will find exciting opportunities and strong organizational 
partners here.
The examples we present in the following section are only the tip of the iceberg. The featured organizations  
and others will continue to work toward policy change in new and different ways not captured in these pages. 
The key takeaway is that changing the system is a high-impact opportunity, and philanthropy can help make  
it happen. 
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High-impact opportunity 3.1
Change systems and policies to reflect the  
evidence base and increase access to care
CORE PRACTICE: System and policy change can happen as a result of direct advocacy, smart partnerships, 
or the development of a compelling evidence base.  What works in any one case might be different from what 
works in another, but the common factor is a coordinating organization with the knowledge and networks to 
assess situations as they evolve, identifying solutions and getting the right people on board to implement them. 
Target Beneficiaries: Populations whose access to care is limited by public or private regulations that are counter-
productive or don’t reflect the evidence. Examples include participants in a particular insurance plan, residents of a 
given state or institution, or everyone who needs a particular kind of care (e.g., a federally regulated medication). 
Impact: More people get access to care now and in the future. 
Cost-per-impact profile: The successful efforts featured here had upfront costs in the $50,000-250,000 range, 
though those costs aren’t always covered by a single donor. Costs vary widely because projects can be very 
different; working for a small policy change at the city level will likely be cheaper than working for sweeping 
federal reforms.  The costs of a single project also don’t reflect that success is often collective, with many people 
and organizations working toward change in slightly different ways. Success can also be cumulative, the product 
of years of work building the credibility and relationships that make an organization influential. The price of any 
single effort gives a helpful sense of scale, but it’s rarely the whole story.
HOW PHILANTHROPY CAN HELP: Philanthropists can support organizations with the demonstrated ability to 
read and influence the policy landscape. The highest-impact targets and strategies can change rapidly, and 
effective organizations will anticipate shifts, move quickly to seize opportunities, and course-correct as needed.
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TAKE ACTION
Donors interested in supporting policy change can look for organizations with the networks and institutional 
knowledge to be effective agents for policy change. For example, if the goal is state-level change, do they have 
the ear of decision-makers in the right agencies? Are they aware of previous efforts so that they can build on 
what’s been done and avoid stepping into a political minefield? Are they connected with other organizations 
working toward similar change? The non-profits featured in the following pages are examples of implementers 
that demonstrate that kind of capacity, but funders can also look for similar groups in their own communities. 
In the following pages, we highlight case examples from the Legal Action Center, COCHS, 
and the Treatment Research Institute. These organizations have consistently demonstrated 
the ability to effectively influence systems and policy and are engaged in this work on an 
ongoing basis. We present these success stories because, while policy change efforts are 
by necessity tailored to a particular time and place, it can still be helpful to see the way 
organizations have tackled this work in the past. With these case examples, we aim to 
accurately reflect the work that’s been done, while providing some insight into what these 
organizations and their peers might accomplish in the future. 
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Success Story
TIPS
What policy-changers 
need to know about 
health care reform
The Parity Act of 2008 
requires insurers 
to keep financial 
requirements and 
treatment limitations 
for mental health and 
SUD benefits no more 
restrictive than those 
for other categories of 
medical benefits. 
The Affordable Care 
Act of 2010 requires all 
insurance plans sold 
on Health Insurance 
Exchanges or provided 
by Medicaid to include 
services for SUDs at 
parity with their other 
medical and mental 
health services.
The Legal Action Center and Health Reform 
For policy change that affects everyone, organizations may need to advocate at the federal level—sometimes 
over the course of years if not decades.. An example of successful federal policy change comes from the 
passage of key provisions in health care reform (see sidebar) and the role of the Legal Action Center (LAC). 
The 2008 Parity Act required large commercial health plans that already provide mental health and substance 
use disorder benefits to deliver them equally—“at parity”—with other medical benefits. The Parity Act was a 
significant step forward, but many plans were exempt, and there was a major loophole: insurers that didn’t 
provide mental health benefits were unaffected by the law. It was therefore simpler for insurers to cut all mental 
health benefits than to provide SUD treatment coverage that complied with the Act.
This was the backdrop leading up to the 2010 passage of the Affordable Care Act. As that law was in 
development, LAC and other advocates saw an opportunity to extend parity protections to millions of Americans 
by closing the loopholes. They advocated for mandates that: 1) required all commercial insurance and expanded 
Medicaid plans to cover addiction and mental health services, and 2) required that this coverage be at parity with 
that for other medical conditions. In combination, these provisions could open up mental health care to tens of 
millions of Americans who previously would have had to pay out of pocket—or, more likely, go without.
To make those changes a reality, LAC spent the two years preceding passage of the Affordable Care Act 
gathering dozens of addiction and mental health organizations and providers into a group that became the 
Coalition for Whole Health. LAC staffed and led the Coalition for Whole Health, coordinated its agenda, and 
worked to create field-wide recommendations. On behalf of the Coalition, LAC and some of its other most 
prominent members circulated these recommendations, educating policymakers in Congress and in federal 
agencies on the need for the proposed changes and the untapped potential to stem the tide of untreated 
addiction and mental health problems in the United States.
Impact: Health care reform has included expanded coverage for mental health care, including SUD treatment.
The federal government estimates that 62 million people will gain coverage for addiction and mental health 
services once parity is fully implemented.185
Costs: It cost LAC approximately $200,000 a year for two years to build the Coalition for Whole Health and 
lead its advocacy related to the Affordable Care Act. These expenses were largely covered by the Open 
Society Foundations. Based on the federal estimate of 62 million individuals gaining mental health coverage, 
LAC received approximately 6.5 cents in grant money for every person who stands to benefit from parity 
expansion. It is important to note, however, that the LAC was able to deliver in part because of its long history 
and knowledge of the sector. Both of these assets were developed long before the single grant in question.
TAKE ACTION
To learn more about improving access to health care through federal and state policy change, visit the Legal 
Action Center’s website at www.lac.org. The Legal Action Center also conducts SUD-related work in criminal 
justice, such as advocacy for alternatives to incarceration. Find out more about the Coalition for Whole Health at 
CoalitionForWholeHealth.org
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Success Story
COCHS: Connections, and an evidence-based care system in Delaware
Community Oriented Correctional Health Services (COCHS) works with the public sector to connect care in the correctional 
system to care in the community, as well as to improve access to substance use and mental health care for the broader 
population. They conduct this work through multiple channels, including working directly with government officials at the 
federal and state level and providing coaching and assistance to organizations facing policy barriers to impact. For example, 
COCHS conducts regular briefings with leadership of the Office of National Drug Control Policy, helping to identify federal 
policy changes that could improve access to SUD treatment in jails and prisons. At the state level, they work with criminal 
justice agencies, health agencies, and other groups. For instance, they are currently working with state policymakers in 
New Jersey to help them expand their mental health coverage to include residential facilities larger than 16 beds. 
In another recent project, COCHS worked directly with a health care provider to help them expand and improve the 
quality of their care. Connections Community Support Programs (Connections) is a non-profit provider of primary and 
behavioral health care, which includes SUD treatment and other mental health services. Via a contract with the state of 
Delaware, Connections was providing behavioral health services within the correctional system and in communities, 
allowing detained individuals to maintain continuity of mental health care when they exited prison. Their primary care 
services were only available outside of the prison system, however, and the split was causing logistical difficulties and 
making it harder for patients to maintain access to the full range of care they needed. To address those issues, Connections 
wanted to provide integrated primary and mental health care within and outside of the correctional system. 
To make that integrated care a reality, Connections needed a primary care contract from the state of Delaware, along with 
their existing contract to provide behavioral health services. For that, they needed increased capacity within their primary 
care services. COCHS helped Connections manage this process, working with them to secure a loan from the Nonprofit 
Finance Fund, which enabled the organization to build the capacity they needed. COCHS and Connections also worked 
together to develop an implementation plan that improved treatment quality within the correctional system.
Impact: Connections was able to bid successfully for the state contract, allowing them to integrate primary care and 
behavioral health for their detainee patient population, estimated at approximately 1,000 individuals per day. 
Their implementation includes expansion of medication-assisted treatment, making medication for opioid addiction 
available to anyone within the justice system who needs it. Prior to these changes, important medications were not 
available to incarcerated individuals (with the exception of pregnant women) despite physician recommendations. 
The impact is meaningful at an individual level to those who struggle with SUDs and are now able to get better 
care. Though it is too early to say, the improved treatment may also result in cost-savings for the justice system by 
breaking the cycle of drug use and recidivism.186 
Costs: For its work coordinating the partnership with Connections, the state of Delaware, and the Nonprofit 
Finance Fund, COCHS spent $150,000, of which 60% ($90,000) was philanthropically funded through the Robert 
Wood Johnson Foundation. The remainder was structured as fee-for-service and paid by Connections. Research 
on similar approaches indicates that the state will likely save money overall due to reduced costs in medical care 
and other services. If that holds true, the philanthropic investment in COCHS will have served as the bridge to 
strategic deployment of public funding for a model that can be sustained over time.
TAKE ACTION
To learn more about COCHS and their work supporting systems and policy change across the country, visit their 
website at www.cochs.org. 
TIPS
Advocacy often 
depends on 
relationships and 
credibility built over 
time. Funders looking 
to support policy 
change should seek 
out organizations 
with demonstrated 
credibility and sector 
knowledge, enabling 
them to bring the right 
stakeholders to the 
table and manage the 
process effectively.
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Success Story
TIPS
Many of the 
organizations profiled 
in these pages are 
well-known to each 
other and often work 
in formal or informal 
collaboration; this 
cross-pollination 
benefits the field, 
allowing for greater 
exchange of 
knowledge and ideas. 
Funders interested in 
supporting research 
or policy change can 
consider funding a 
joint effort or working 
with an organization 
with the reputation and 
capacity to mobilize 
networks effectively. 
Treatment Research Institute (TRI) and the  
move toward a transparent treatment market
The Treatment Research Institute (TRI) conducts research in substance use treatment, policy, and delivery and 
works with public and private stakeholders to help translate those findings into practice. 
TRI’s work is an example of systems change outside of the political setting. Research and the dissemination 
of new ideas can change systems from the bottom up, for example, when a consumer seeks out a particular 
evidence-based therapy that they have read about. Research can also make an impact from the top down, 
such as when an insurance company uses new evidence to decide which treatments to fund. As both of these 
examples illustrate, when research is available and accessible, it can make an impact by influencing markets. The 
process is often slow and non-linear, but the change can be both lasting and meaningful.
An early example of this is the study that showed SUDs to be a chronic mental illness, published in the Journal 
of the American Medical Association in 2000.187 This study, led by TRI researchers, has been cited widely to 
support the need to treat SUDs as a health issue rather than simply a matter of criminal justice. 
Recent health care reform offers an illustration of systems change through applied research. Under the Affordable 
Care Act, insurance coverage, and therefore, demand for treatment services are expected to increase. However, 
there is no standardized tool to assess whether treatment programs can deliver the level of care necessary to 
meet patient needs. Without the right information, there are few ways for consumers (individuals or insurers) 
to choose effective treatment options over less-effective ones. To address this gap, TRI is in the early stages 
of developing quality assessment tools and training protocols to be used by Medicare and Medicaid, among 
others. 
Impact: The reconceptualization of SUDs as a chronic medical illness was a key factor enabling SUD treatment’s 
inclusion as an “essential health benefit” under health care reform.188 (For more on the impact of health care 
reform, see page 40 for related work by the Legal Action Center.)
The treatment quality  assessment tools are expected to improve the overall quality of SUD care, as increased 
transparency makes it possible for market forces to incentivize good treatment outcomes. Without that 
transparency, consumers are left to rely on less-relevant but more visible factors such as price, luxury amenities, 
or size, and treatment centers will continue to direct their resources toward those aspects of their program.
Costs: Projects such as the assessment tools may take a year or longer, with typical costs in the range of 
$200,000. However, that funding can be a mix of philanthropic and public dollars, as TRI receives government 
support for some research activities. 
TAKE ACTION
To learn more about TRI and their research into addiction treatment, policy, and health systems improvement,  
visit their website at www.tresearch.org
Strategy 4
Fund Innovation to Improve 
Prevention and Treatment
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STRATEGY 4 Fund innovation to improve  prevention and treatment
In earlier sections, we’ve presented strategies to lift the burden of SUDs. But even the best strategies based on 
the best evidence available are operating without the answers to important questions. Those big unanswered 
questions are promising targets for research and innovation and can lead to some of the most exciting 
opportunities for philanthropy to make a lasting impact. High-impact targets include SUD prevention, better 
treatment, improved access to treatment, and reduced stigma. 
In the following pages, we summarize key findings and highlight promising practices in prevention. We also note 
promising directions for research and innovation and resources to help funders identify specific opportunities..
HIGH-IMPACT RESEARCH OPPORTUNITIES IN PREVENTION
The importance of preventing SUDs among adolescents is undisputed. Adolescents are the highest-risk age 
group for new SUDs, and preventing or delaying substance use can have protective effects. For example, each 
year a teen delays alcohol use decreases their chances of developing an alcohol use disorder by 14%.189 For 
that reason, there are hundreds of adolescent substance abuse prevention programs operating within schools 
and communities across the country. It’s a well-studied topic, with an extensive body of academic literature. 
And it’s a well-funded goal: in FY 2015 alone, the federal government allocated $1.3 billion for substance abuse 
prevention efforts in schools and communities.190 However, despite all of those efforts, much of what’s currently 
done in the name of SUD prevention isn’t effective in preventing substance use. 
What does that mean for philanthropy? This is an area with a great deal of room for innovation. Given the 
potential benefit of effective prevention, even moderate progress can yield major social impact. 
Despite the prevention field’s limited success to date, funders interested in prevention are by no means flying 
blind. While the sector has not cracked the code on prevention, there are lessons learned and promising paths 
to pursue. A common theme is that they need more evidence of impact in different settings and for different 
populations before donors should consider replicating them widely. 
In the following pages, we present promising targets for research and innovation, along with resources to help 
interested funders learn more about existing efforts they can build upon.
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HIGH-IMPACT RESEARCH OPPORTUNITY:  
Testing the impact of prevention programs that have shown promise in particular settings
Before promising pilot programs can be rolled out on a large scale, they need to be tested within different settings and 
populations so that researchers and practitioners can understand what the programs really accomplish and for whom. 
Philanthropy can support that analysis, bridging the gap from a new idea to full-scale implementation. In many ways, 
this research is a win-win. Learning what works is always the goal, and it’s exciting if a new program shows real impact. 
But even if the results aren’t so positive, learning what doesn’t work is still an important step toward impact.
Donors interested in this opportunity can look for programs with (1) well-supported theories of change, (2) promising 
evidence of impact, and (3) data limitations that can be addressed with additional research. The examples that follow 
have strong evidence from well-designed studies, making them among the most promising targets within the over 50 
interventions we reviewed. However, one has demonstrated results only in a particular population, while the other has 
not consistently replicated effects on substance use—but has repeatedly shown other positive impacts.
PROMISING INNOVATION TARGET:  
Integrate prevention programs at the community level
The theory: Taken as a whole, the evidence indicates that any single prevention program is unlikely to deliver 
major reductions in substance use. However, combining programs to weave a web of support may make a 
greater difference than the individual programs on their own. The hope is that programs can reinforce each other 
in a way that’s multiplicative rather than additive. 
The model: Promoting School-community-university Partnerships to Enhance Resilience (PROSPER), a partnership 
program between local communities and land-grant universities, is a system to deliver a suite of programs within 
a community. The programs themselves are chosen by community representatives from a list of evidence-based 
approaches provided by researchers. Community representatives select one family-focused program to deliver in 
6th grade and one school-based program to deliver in 7th grade. A team based out of a state university helps the 
community implement the selected programs. 
What we know: In a randomized controlled trial of PROSPER implementations in Iowa and Pennsylvania, 
researchers found that the program decreased use of a number of substances (not including tobacco or alcohol) 
by approximately 4 to 6 percentage points.191 
What we hope to learn: One important question is whether these results are replicable and generalizable to different 
populations. The trial was conducted in a population of mostly Caucasian, relatively affluent adolescents in rural areas. 
Further research is needed to test PROSPER in different settings and better understand the populations for which it 
can be reliably effective. More research is also needed to understand how much of the effect is due to the delivery 
system—which is the core of the PROSPER approach—or the specific interventions chosen by the communities. 
Implications for funders: The idea of integrating different programs to create a supportive community is an 
exciting one, but still too new to replicate widely. This is a great avenue for further research, whether focused on 
new populations, new combinations of approaches, new delivery systems, or all of the above.
LEARN MORE & TAKE ACTION
Dr. Richard Spoth out of Iowa State University developed PROSPER and is currently leading research efforts on the 
program. (Visit www.ppsi.iastate.edu to learn more.) A similar program with promising results is Communities That 
Care, currently studied by the University of Washington’s Social Development Research Group. (Visit  
www.sdrg.org to find out more.)
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For more on working 
with grantees to 
understand their impact, 
see our guide Beyond 
Compliance: Measuring 
to learn, improve, and 
create positive change.
For more on supporting 
early-childhood efforts, 
see our early-childhood 
toolkit for funders, 
Invest in a Strong Start 
for Children. 
PROMISING INNOVATION TARGET: 
Focus on healthy child development for positive impacts in adolescence and beyond
The theory: Many of the known risk factors for SUDs are also known risk factors for other negative outcomes 
such as high school drop-out or teen pregnancy. Promising approaches might target those risk factors early, 
tackling SUD prevention as part of a broader set of healthy development goals. 
The model: The Good Behavior Game (GBG) is designed to improve first-grade classroom behavior and help 
children see themselves as members of a classroom community. In GBG classrooms, there are clear, consistent, and 
transparent rules for behavior. Children are divided into teams of 2-5 students, and the team gains or loses points 
based on the behavior of its members. The hope is that giving kids tools to manage their behavior early can help 
them make good choices—such as steering clear of substance use—over the long term. 
What we know: GBG has demonstrated positive impacts, particularly for boys, but it doesn’t always reduce substance 
use. Substance use is only one of several problem behaviors that GBG targets. In one of the first GBG studies, low-
income African American students in Baltimore were randomized into GBG classrooms and tracked from first grade 
to age 19. The young men in the GBG classrooms showed significant reductions in illicit drug use (excluding alcohol 
and marijuana) at age 13 and increased academic achievement and reduced behavioral problems at age 19. (The 
researchers did not report information about substance use at age 19.) The impact was greatest among male children 
who ranked highest on measures of aggressive and disruptive behavior. There was no effect on female children.192
What we hope to learn: The biggest question about GBG is whether it can reliably and consistently get results in 
different settings. The same researchers in the same Baltimore schools mentioned above tried to replicate their 
results with the next class of first-graders entering school, but they did not see the same impacts. Other studies 
on GBG have been conducted in Oregon and in Europe. Positive impacts on disruptive and aggressive behavior 
have been consistently replicated, but impacts on substance use have not.
Implications for funders: GBG has been a good and helpful program for children. It’s just not clear whether or not 
it’s also a good way to prevent substance use. Philanthropists can support research to understand how, when, 
and for whom it might impact substance use in particular, knowing that even without an effect on substance use, 
the program is likely to be a positive influence in children’s lives.  
LEARN MORE & TAKE ACTION
The Johns Hopkins Center for Prevention and Early Intervention is researching strategies such as the Good 
Behavior Game to improve classroom behavior and outcomes and to prevent behavioral problems, including 
substance abuse, among youth. To contact the Center and support their work, visit their website at http://www.
jhsph.edu/research/centers-and-institutes/johns-hopkins-center-for-prevention-and-early-intervention/.
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HIGH-IMPACT RESEARCH OPPORTUNITY:  
Target risky drinking in adolescents with secondary prevention
Alcohol is the most commonly used substance, and alcohol use disorders are the most common type of SUD among 
teens as well as adults.  In 2013, for example, the rate of current alcohol use among youths aged 12 to 17 was 12%, and 
the rate of binge drinking was over 6%.193 However, even the most promising primary prevention efforts—those that aim 
to prevent any use of alcohol—have not delivered reductions in teen drinking.  While innovation in primary prevention is a 
worthwhile goal, there may be opportunities to make a difference by focusing on the riskiest users and helping them curb 
their use. This strategy has been effective in adults, and early research indicates that it may work for adolescents as well.  
PROMISING INNOVATION TARGET:  
Secondary prevention for adolescents
The theory: Secondary prevention efforts, which focus on stopping the progression from risky use to disorder, 
have been effective among adults and may be a promising approach for adolescents as well.
The model: Under the SBIRT protocol (also discussed on page 30), all patients in participating health care 
settings automatically undergo a quick screening to assess their alcohol and drug use. If their use puts them at 
risk of developing a serious problem, they receive a brief intervention that focuses on raising their awareness 
of substance abuse and motivating them to change their behavior. Patients who need more extensive treatment 
receive referrals to specialty care.
What we know: A meta-analysis found that brief alcohol interventions can lead to modest but statistically 
significant reductions in risky drinking among adolescents and young adults. The effects persisted for up  
to one year after intervention.194 
What we hope to learn: The evidence base for SBIRT is still much stronger for adults. More research and testing  
are needed in settings like school health clinics where more adolescent patients can be reached. There may be 
ways to tailor the content of the brief intervention to make it more effective for a younger population.
Implications for funders: SBIRT offers a way to target prevention and early intervention toward the adolescents 
who need it most, but there are still questions about how best to deliver it and what impact might be possible. 
Philanthropy can support research into new settings and other adjustments to potentially make this a powerful tool 
to reach adolescents. In addition, learning more about how it works (or doesn’t work) for adolescents might yield 
insights about how other services, such as SUD treatment, can be tailored for adolescents.
LEARN MORE & TAKE ACTION
The University of Minnesota’s Center for Adolescent Substance Abuse Research (www.psychiatry.umn.edu), 
in collaboration with Kaiser Permanente, is conducting a study on an SBIRT model for primary care and school 
settings that is tailored to adolescents experiencing mild to moderate drug involvement. 
A partnership led by the research center NORC at the University of Chicago is working to engage social work and 
nursing schools in a learning collaborative to create an effective SBIRT curriculum to integrate into the students’ 
training. Community Catalyst, a consumer advocacy group, is developing consumer-led advocacy campaigns in five 
states (Georgia, Massachusetts, New Jersey, Ohio, and Wisconsin) to enact state policy change to increase funding 
and training for SBIRT. The Conrad N. Hilton foundation is funding SBIRT research and implementations in multiple 
sites. See norc.org, communitycatalyst.org, and hiltonfoundation.org for more.
TIPS:
• Primary Prevention 
of SUDs is the 
prevention or 
delaying of the start 
of substance use 
among a general 
population of 
adolescents, such as 
all teens in a state, 
county, or school 
district.   
• Secondary 
Prevention of SUDs 
is preventing risky 
substance use from 
progressing to a 
SUD in individuals.
• Tertiary Prevention 
of SUDs is providing 
time, cost, and 
labor-intensive care 
to patients who are 
acutely or chronically 
ill with a SUD. 
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HIGH-IMPACT RESEARCH OPPORTUNITY:  
Learn from successful behavior change efforts in related fields
While the evidence base for successful interventions in SUD prevention is relatively slim, there have been 
successful behavior change efforts in related fields that can provide a jumping-off point for further research. 
Anti-tobacco and anti-drunk-driving campaigns have both had successes with efforts focused on changing 
perceptions of what’s normal in one’s peer group (see box on following page). Other insights from behavioral 
science might be relevant as well. Researchers are learning more and more about the way small tweaks to 
the wording of a message can change people’s responses, as well as the importance of choosing the right 
messenger..195  
Behavior change research can also tell us a great deal about what doesn’t work—and what may even cause 
harm. It may make intuitive sense that telling kids about the dangers of drug use would keep them away from 
drugs, but research has demonstrated that it doesn’t work. D.A.R.E. (Drug Abuse Resistance Education), a popular 
school-based program delivered by police officers, was used in 80% of American school districts in 2001.189 The 
program was started and delivered by police officers and focused on educating children and teens about the 
risks of drug use. Somewhat infamously, however, multiple studies have shown that D.A.R.E. had no effect on 
substance use behavior in teens and may even have increased some participants’ curiosity about substance 
use.190 Similarly, the much-touted and still publicly funded Meth Project uses graphic and shocking ads to illustrate 
the dangers of meth, but researchers found that it had no effect on actual meth use.198 
The same pattern holds in anti-tobacco campaigns. Teens actually overestimate the risk of smoking, but that 
doesn’t translate to any change in their behavior.199 A related sector, criminal justice, also shows this effect: Scared 
Straight, the popular program in which prison inmates warn children away from a life of crime, has actually been 
shown to increase the likelihood of juvenile delinquency.200
Avoiding scare tactics does not mean avoiding honest discussion and education. Consider the depiction of 
teenage pregnancy in the MTV reality series “16 and Pregnant.” The show is marketed to adolescents and 
follows the lives of pregnant teens and their families, exposing youth to information that would otherwise be less 
visible, particularly in areas that utilize abstinence-only education. Research shows that “16 and Pregnant” led 
to increased online searches for information regarding birth control and teen pregnancy. Researchers link that 
increase in knowledge to a marked change in behavior and a decline in teen birth rates during the first 18 months 
following the show’s release. Declining abortion rates during the same time indicate the reduced birth rates were 
the result of fewer pregnancies.201
The line between appropriate information and scare tactics can be difficult to find, making it a potentially valuable 
area for further investigation.
Any teenager 
could explain why 
[scare tactics don’t 
work]. For them, 
a cigarette is not 
a delivery system 
for nicotine. It’s a 
delivery system for 
rebellion. Kids take 
up smoking to be 
cool, to impress 
their friends with 
their recklessness 
and defiance of 
adults. They know 
that smoking is 
dangerous. ... 
Danger is part of a 
cigarette’s appeal.
–Tina Rosenberg, 
journalist, on why tobacco 
companies support scare-
tactic advertising202
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PROMISING INNOVATION TARGET:  
Using social norms to spur behavior change
The theory: As the advertising industry has long known, people are influenced by what they perceive as the 
behavior of their peers.  Using media to change the perceptions of what’s normal in substance use might help 
reduce use by removing the powerful incentive to fit in. 
The model: The 1998 Truth Campaign, a counter-marketing campaign to reduce smoking among Florida teens, 
used an advertising agency to produce billboards and television ads aimed at exposing the tobacco industry’s lies 
and manipulations toward teens, using teens themselves as the messengers. It worked by creating a new target 
for teens to rebel against—the tobacco industry rather than the public health establishment—and by creating a 
visible peer group of teens who weren’t taken in by Big Tobacco. That gave kids a new, healthier social norm. 
The 1988 Harvard Alcohol Project aimed to spread the concept of the “designated driver” throughout America. 
With the support of leading television networks and Hollywood studios, writers inserted drunk driving prevention 
messages (including references to designated drivers)  into scripts of popular shows such as “Cheers” and “L.A. 
Law” over a four-year period.
What we know: The anti-tobacco campaign was successful: Florida teen smoking rates were cut in half in less 
than a decade.203 The designated driving campaign was also successful: a 1991 poll showed that 9 out of 10 
respondents were aware of the designated driver program. Researchers believe that the initiative was a major 
contributing factor to the 30% decline in alcohol-related traffic fatalities from 1988-1994, a decrease that saved 
over 50,000 lives.204
What we hope to learn: Both of these campaigns were launched over a decade ago, when media consumption 
patterns were different and there were fewer alternate avenues for social norm messages. More work is needed 
to understand how similar efforts might be adapted to the new media landscape. More research could also 
illuminate how well these programs can work when there’s a strong social norm reinforcing the targeted behavior. 
For example, can an ad campaign counteract the celebration of drinking on a college campus?
Implications for funders: Media campaigns can make a difference, but they’re likely to be more effective if 
they’re developed based on what we know about human behavior—in particular, tapping into the powerful drive 
to fit in with one’s peers. Funders should be wary of prevention efforts that are overly focused on highlighting 
risks, despite the intuitive appeal that many of these programs hold. Better evidence can reduce spending on 
unsuccessful efforts and help the field get closer to what works.
LEARN MORE & TAKE ACTION
Many public health schools have departments dedicated to using behavioral science to improve health. 
Researchers in these departments can be a great place to start. Organizations like the Partnership for  
Drug-Free Kids (www.drugfree.org/) that support ad campaigns and other kinds of outreach can also be  
partners in this research.
The University of Pennsylvania’s Annenberg School (www.asc.upenn.edu) and other schools of communication are 
good resources for more information about the role media can play. 
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HIGH-IMPACT RESEARCH TARGETS IN SUD TREATMENT AND BEYOND
Few people with SUDs get treatment, and, of those, few achieve recovery the first time they try.205 Research into 
treatment improvements can focus on getting more people into treatment or on new treatment tools that will be 
more effective for more people. Both pieces are needed to make care more effective, more personalized, and 
perhaps most importantly more available to SUD patients no matter where they live and work.
New treatment tools
We know that there are treatments that work—for some people, sometimes. But there’s potential to do so much 
more. Researchers have only just begun to tap the potential of research in genetics, pharmacology, and even 
immunology. A vaccine against addiction might sound far-fetched, but there’s research into it happening right 
now. It might never work, but if it does, the potential for impact is enormous. Much of the work in new treatment 
development is funded by public dollars via research agencies like the National Institutes of Health. However, 
private philanthropy has the potential to contribute in meaningful ways. 
LEARN MORE & TAKE ACTION 
Universities often have research centers dedicated to particular topics or types of research, including those 
related to substance use. For example, The Perelman School of Medicine at the University of Pennsylvania 
includes the Center for Studies of Addiction, which conducts research into topics like the genetics of addiction 
and new medications to treat the disorder. Scripps University hosts the Pearson Center for Alcohol and 
Addiction Research, where researchers are studying the use of new compounds to control the effect of 
substances on the brain to prevent relapse during recovery. The National Institute on Drug Abuse (NIDA) 
maintains research consortia on multiple topics in SUD treatment and delivery.
To learn more about strategic approaches to research funding more generally, see resources from FasterCures.org,  
a non-profit dedicated to investments in medical research.
Better treatment delivery 
Improving treatment delivery is an important goal that can be approached in many different ways. For example, 
providing care remotely via computer has shown promise in other chronic conditions, such as depression and 
heart disease, and could open up access to care for those unable to access a specialized facility. The National 
Institute on Drug Abuse is supporting researchers working toward mobile health (mhealth) solutions to help SUD 
patients remain on track to recovery and maintain the health of drug users with other medical problems such 
as HIV. Using mobile technology, this method sends reminder messages about medication and skills learned in 
treatment. Such technology can also track patients’ progress in real time.
LEARN MORE & TAKE ACTION 
Dartmouth College’s Center for Technology and Behavioral Health (CTBH) conducts research into promising 
technologies for improving and delivering better SUD treatment. Columbia University’s CASAColumbia research 
center works on topics in treatment delivery as well as other systemic issues related to SUDs. 
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Reduced stigma and discrimination
Underlying many of the issues outlined in this report is the question of stigma and, relatedly, discrimination. As 
this report emphasizes, we have tools that can make a difference, but those tools could be even more effective 
if people could seek help without the fear—or the reality—of being stigmatized. Stigma, misinformation, and 
stereotypes regarding who has substance use disorders has made addiction a politically unpopular topic. As 
a result, research funding has been difficult to secure, and innovation has been slow. It’s not obvious how to 
conquer stigma and the discrimination that often accompanies it, but there’s a role for philanthropy in helping 
to figure that out. Research on stigma itself can help us understand how to change hearts along with minds. 
For example, one thing we do know is that personal contact is the most powerful force against stigma.206 What 
we don’t yet know is how to harness that to make a difference on a large scale. And, finally, there is a role for 
philanthropists—and all other advocates for SUD patients—in simply speaking up about the ways SUD patients 
suffer and the ways we can all help.
LEARN MORE & TAKE ACTION 
The Annenberg Public Policy Center conducts research on the stigma of mental illness. Researchers out of Boston 
University are exploring language’s impact on stigma and how changing the way we speak about substance 
abuse and addiction can change negative outcomes that often result from stigma. Former House Representative 
Patrick Kennedy, a recovering addict and founder of the Kennedy Forum, is a dual funder and advocate who 
openly shares his story of addiction and recovery.
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Conclusion
Conclusion
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The harm caused by substance use disorders is real and widespread. Fatal overdoses from opiates (pills and 
heroin) alone now surpass traffic fatalities in the U.S.,208 while nearly a third of traffic fatalities involve drivers under 
the influence of alcohol.209 The associated costs of substance abuse disorders in both human and economic 
terms are enormous. But there are concrete things that donors can do right now to prevent deaths, lower human 
and economic costs, improve access to effective treatment, and build a stronger foundation for addressing SUDs 
now and in the future. Some final takeaways:
Helping people with SUDs with tools we already have isn’t just the humane thing to do, it’s the smart thing 
to do. One of the biggest gaps between current knowledge and practice is in the realm of opportunities to save 
lives and make life a little bit better for people with SUDs right now, even before they have achieved recovery 
or sobriety. Overdose prevention, clean syringes, housing, and legal support offer people with SUDs a chance 
to protect themselves and others. Such treatments also offer people with SUDs the chance to be treated with 
the respect and care that can be a first step to beginning a process of recovery. From care providers and SUDs 
sufferers themselves, we heard over and over how much of a difference a safe and respectful environment can 
make in someone’s quality of life and sense of self. From researchers and economists, we heard how much of a 
difference these tools can make in reducing costs to taxpayers and health risks to the general population. 
Evidence-based treatment works for many patients, but most people never get a chance to try. The narrative 
of the SUD patient in popular culture is often a hopeless one, a spiral towards “rock bottom” that ends in abject 
suffering and death. There’s no denying the reality of that story for some, but a more hopeful story is possible. 
There are many treatment approaches that we know can work, alone or in combination, from mindfulness 
training, to cognitive behavior therapy, to medication. Most people with SUDs don’t get the benefit of those 
options. Instead they are offered the same narrowly defined treatments again and again—if they get anything at 
all. Organizations that help build health care providers’ capacity to provide personalized, evidence-based care 
can help get more people to recovery more quickly, often saving money in the process.
Current laws and care systems aren’t working, but there’s an exciting opportunity for change. Among 
researchers, policymakers, and care providers, there is excitement as well as trepidation about the changes 
to come from the recent passage of the Affordable Care Act and the Parity Act. The laws have been passed, 
but the impact will be determined by the implementation. This transitional time creates an unusual opportunity 
for philanthropists interested in policy and systems change. Often, policy change is a long, slow grind, with 
change coming incrementally if at all. But right now, change is happening at a comparatively breakneck pace. 
Organizations like Treatment Research Institute, the Legal Action Center, and others are working across the 
public and private sectors to help shape implementation and move care providers and policymakers toward  
what we know works. It’s too early to know how all of this will play out, but there are exciting opportunities to  
help keep it moving in the right direction. 
The various opportunities detailed in this report represent a menu for action. Not all will appeal to every 
donor, but all have been chosen as having potentially high impact, evidence of effectiveness, and a clear role for 
philanthropy. In developing the report, our team spoke with dozens of experts in the field, conducted site visits 
and reviewed over a hundred studies and reports. 
As always, we hope this work helps donors move from good intentions to action and, ultimately, to lifting the 
burden of SUDs for everyone affected by the disorder. 
We must bolster 
our current 
approach to 
addiction with more 
common sense. 
We must address it 
as a public health 
crisis, providing 
treatment and 
support, rather 
than simply doling 
out punishment, 
claiming victory, 
and moving on to 
our next conviction.
– Peter Shumlin, 
Governor of Vermont, 
on the state’s heroin 
emergency207
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Looking for evidence-based solutions
To identify high-impact philanthropic opportunities, our multi-disciplinary team accesses the best available 
information from three sources: rigorous academic research, informed opinion, and field experience. From all 
three sources, we seek an empirical understanding of where the unmet needs are, what practices address 
these needs well, what social impact these practices generate, and how much change costs. By tapping all three 
sources, we leverage the strengths of each, while mitigating their weaknesses. Where all three sources point to 
the same practice or model, we see a high-impact opportunity. 
 
Sources reviewed
We reviewed over 300 sources and interviewed over 70 experts in academia, policy, philanthropy, health 
systems, care provision, and more. Our collaboration with the Treatment Research Institute (TRI) is of particular 
note. TRI is a leading center for substance use disorder research, and TRI staff members served as expert 
resources throughout the project.
Field Experience
Most-Promising 
Approaches
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Field Experience
• Practictioner and beneficiary insights
• Performance assessments
• In-depth case studies
Informed Opinion
• Stakeholder input
• Expert opinion
• Policy analyses
Academic Research
• Randomized controlled trials and  
quasi-experimental studies
• Modeled analyses (e.g., cost-
effectiveness)
SOURCES OF INFORMATION
Broad evidence base, targeted focus on social impact
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Criteria for inclusion of opportunities in this report
After conducting our initial scan of the three circles of evidence noted above, we generate a list of potential 
philanthropic opportunities to highlight. We then analyze each approach to determine how it stacks up against 
our four criteria:
• Strength of evidence: Is there a body of evidence supporting the link between the approach and the targeted 
social impact? Does that evidence come from each of the three circles. How does the strength of evidence for 
this approach compare with the evidence for other approaches aiming to achieve the same outcomes?
• Expert recommendation: Do experts across the three circles of evidence (including those whose expertise 
comes from lived experience) see potential for social impact as a result of this approach?
• Potential for impact: If the approach is successful, how many people will experience a positive change in their 
lives, and how meaningful will that change be? Does this approach have the potential to demonstrate a more 
powerful or efficient way to get to positive impact? If it is not successful, is there potential for negative impact 
(as compared with the negative impact of doing nothing)?
• Philanthropic on-ramp: Are there ways in which philanthropic support could create high impact? Are there 
credible implementers who could put this approach into practice? Is it clear where funds could be donated to 
implement this approach? Is it redundant given government programs or market forces?
We seek to highlight opportunities with: strong evidence of a link to the target impact; expert and constituent 
support; potential for meaningful and potentially game-changing impact; minimal potential for negative impact; 
and the ability to leverage philanthropic funding. Within opportunities that approach those benchmarks, we 
analyze and present costs and impacts, facilitating appropriate comparisons and clarifying trade-offs. 
As with all of the Center’s work, this report summarizes evidence drawn from a range of sources, including 
academic research, policy experts, and practitioners in the field. As we present a range of opportunities to serve 
different populations or target different levers for change, some options may have stronger evidence from one 
dimension than from another. For example, since health service interventions can be replicated and studied in 
different settings, the academic evidence base in health services is sometimes deeper than the evidence base in 
policy change. However, since a single policy change can affect large populations for an extended period of time, 
those interventions can be extremely cost-effective—if they are successful. 
Broad evidence base, targeted focus on social impact
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